Forskningsområdet Neurologi vid Karolinska Institutet – Danderyds sjukhus

Publikationer

Alla gruppmedlemmars publikationer

• Article: FOLIA PHONIATRICA ET LOGOPAEDICA. 2025;:1-14

  Sensory Profiles in Children with Speech Sound Disorders

  Bjorelius H; Tukel S; Tsilingaridis G; Malmenholt A; Terband H
• Article: TRANSFUSION AND APHERESIS SCIENCE. 2025;64(5):104208

  The number of apheresis procedures to treat immune-mediated neurological diseases is on the rise

  Le Poole K; Vrielink H; Aandahl A; Glatt TN; Skosana Y; Hridlickova R; Blahutova S; Lanska M; Deeren D; Griscevicius A; Audzijoniene J; Newman E; Gasova Z; Ludvikova ZB; Witt V; Berlin G; Kielstein J; Cengiz G; Ott M; Svenningsson A; Stegmayr B
• Article: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2025;96(10):966-974

  Factors associated with outcomes following autologous haematopoietic stem cell transplantation for multiple sclerosis

  Noui Y; Zjukovskaja C; Silfverberg T; Ljungman P; Kultima K; Tolf A; Tolf T; Carlson K; Burman J; AutoMS SI
• Article: HEADACHE. 2025;65(8):1294-1307

  Characterization of insomnia and sleep quality in a cohort with cluster headache

  Jennysdotter Olofsgard F; Ran C; Spulber S; Steinberg A; Sjostrand C; Waldenlind E; Lantz M; Sundholm A; Soderstrom M; Dahlgren A; Belin AC
• Article: EUROPEAN ARCHIVES OF PAEDIATRIC DENTISTRY : OFFICIAL JOURNAL OF THE EUROPEAN ACADEMY OF PAEDIATRIC DENTISTRY. 2025;:1-11

  Chewing efficiency in children with motor speech disorders

  Bjorelius H; Tsilingaridis G; Johansson F; Trang J; Grigoriadis A; Thorman R; Terband H
• Article: MOVEMENT DISORDERS CLINICAL PRACTICE. 2025

  Orthostatic Tremor Is Evoked by Muscle Load Without the Need for Orthostatic Position

  af Edholm K; Uribarri G; Sundgren M; Svenningsson A; Fransen E
• Journal article: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2025;99:106479

  Comparison of CSF biomarkers in multiple sclerosis patients treated with natalizumab and rituximab.

  Hellgren J; Ahlström I; Strandberg MC; Jonsson MF; Hansson O; Janelidze S; Svenningsson A; Källén K
• Article: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2025;99:106479

  Comparison of CSF biomarkers in multiple sclerosis patients treated with natalizumab and rituximab

  Hellgren J; Ahlstrom I; Strandberg MC; Jonsson MF; Hansson O; Janelidze S; Svenningsson A; Kallen K
• Article: ACTA ANAESTHESIOLOGICA SCANDINAVICA. 2025;69(5):e70031

  Identifying dysphagia in the intensive care unit: Validation of the Swedish version of the Gugging swallowing screen-Intensive care unit

  Schandl A; Bergstrom L; Selg J; Eliasson A; Hylen M; Silfwerbrand F; Nymark L; Mcgreevy J; Brorsson C; Holmlund T; Haegglund P
• Doctoral thesis: 2025

  Ischemic stroke in working ages : large vessel occlusion, work capacity and outcome after thrombectomy

  Roland M
• Thesis / dissertation: KAROLINSKA INSTITUTET. 2025

  Ischemic stroke in working ages : large vessel occlusion, work capacity and outcome after thrombectomy

  Roland M
• Article: DYSPHAGIA. 2025;40(2):343-352

  Validity and Reliability of Dysphagia Outcome Severity Scale (DOSS) When Used to Rate Flexible Endoscopic Evaluations of Swallowing (FEES)

  Fransson J; Thoren S; Selg J; Bergstrom L; Hagglund P
• Article: FRONTIERS IN NEUROLOGY. 2025;16:1549537

  Prevalence of large vessel occlusions in an unselected hospital-based stroke cohort in Sweden

  Roland M; Markaki I; Arnberg F; Klironomos S; Sjoestrand C
• Article: JOURNAL OF STROKE & CEREBROVASCULAR DISEASES. 2025;34(3):108236

  Sickness absence and disability pension in patients treated with mechanical thrombectomy

  Roland M; Rudberg A-S; Arnberg F; Alexanderson K; Sjostrand C
• Article: EUROPEAN STROKE JOURNAL. 2025;10(1):268-277

  Sickness absence and disability pension patterns before and after ischemic stroke: A Swedish longitudinal cohort study with matched references

  Roland M; Rudberg A-S; Alexanderson K; Sjostrand C
• Conference publication: CLINICAL NEUROPHYSIOLOGY PRACTICE. 2025;10:S719-S720

  Cortical response to proprioceptive stimulation in primary orthostatic tremor-a magnetoencephalography study

  af Edholm K; Vinding MC; Pfeiffer C; Svenningsson A; Fransen E; Sundgren M; Sjostrom H; Edvall N; Lundqvist D; Waldthaler J
• Article: DYSPHAGIA. 2024;39(6):1078-1089

  Swallowing Characteristics and Water Swallow Capacity in Patients with Parkinsonism

  Martell P; Skogar O; Bergstrom L
• Journal article: EUROPEAN HEART JOURNAL. 2024;45:ehae666.2619

  Interaction between subclinical carotid atherosclerosis endotype and biological sex: a study from IMPROVE cohort

  Chen Q; Bergman O; Ziegler L; Baldassarre D; Tremoli E; Strawbridge R; Eriksson P; Gigante B
• Article: HEALTH EXPECTATIONS. 2024;27(5):e70057

  Feasibility, Fidelity and Acceptability of a Person-Centred Care Transition Support Intervention for Stroke Survivors: A Non-Randomised Controlled Study

  Lindblom S; Flink M; von Koch L; Laska AC; Ytterberg C
• Article: ANNALS OF NEUROLOGY. 2024;96(4):678-693

  COMBAT-MS: A Population-Based Observational Cohort Study Addressing the Benefit-Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab

  Piehl F; Alping P; Virtanen S; Englund S; Burman J; Fink K; Fogdell-Hahn A; Gunnarsson M; Hillert J; Langer-Gould A; Lycke J; Mellergard J; Nilsson P; Olsson T; Salzer J; Svenningsson A; Frisell T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2024;30(3):1072-1073

  Clinical Effectiveness and Safety of ofatumumab for Patients Treated since March 2021 in the Swedish post-market surveillance study "Immunomodulation and Multiple Sclerosis Epidemiology 12" (IMSE 12)

  Larsson V; Forsberg L; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2024;30(3):1086-1087

  Clinical Effectiveness and Safety of Dimethyl Fumarate for Patients Treated at least 6 Years in the Swedish post-market surveillance study "Immunomodulation and Multiple Sclerosis Epidemiology 5" (IMSE 5)

  Forsberg L; Larsson V; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2024;30(3):665-666

  Clinical Effectiveness and Safety of Cladribine Tablets for Patients Treated at least 24 Months in the Swedish post-market surveillance study "Immunomodulation and Multiple Sclerosis Epidemiology 10" (IMSE 10)

  Larsson V; Forsberg L; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2024;30(3):658-659

  Clinical Effectiveness of Cladribine Tablets for Patients Below or Above 45 years of age at treatment start in the Swedish post-market surveillance study "Immunomodulation and Multiple Sclerosis Epidemiology 10" (IMSE 10)

  Larsson V; Forsberg L; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2024;30(3):1069-1070

  A comparison of administration and discontinuation of Natalizumab in Sweden over time for patients treated with either subcutaneous (SC) or intravenous (IV) administration methods since July 2021

  Forsberg L; Larsson V; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Sundstrom P; Martin C; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2024;30(3):1088-1089

  P1721/2323 CLADCOMS - CLADribine tablets long-term Control Of MS - a post-marketing investigator driven study

  Larsson V; Forsberg L; Nilsson P; Magdalena LA; Svenningsson A; Gunnarsson M; Ayad A; Mellergard J; Vrethem M; Burman J; Lycke J; Piehl F; Fink K
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2024;30(3):484

  Prescription of Antibiotics in Patients with Multiple Sclerosis Treated with Rituximab: a 10-year Retrospective Cohort Study

  Lange N; Gunnarsson M; Tina E; Hultgren O; Svenningsson A
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2024;30(3):87-88

  COMBAT-MS: A population-based observational cohort study addressing the benefit-risk balance of Multiple Sclerosis therapies compared with rituximab

  Piehl F; Alping P; Virtanen S; Englund S; Burman J; Fink K; Fogdell-Hahn A; Gunnarsson M; Hillert J; Gould AL; Lycke J; Mellergard J; Nilsson P; Olsson T; Salzer J; Svenningsson A; Frisell T
• Conference publication: JOURNAL OF SLEEP RESEARCH. 2024;33

  Investigating insomnia and burnout in a cluster headache cohort

  Olofsgard FJ; Ran C; Soderstrom M; Steinberg A; Waldenlind E; Sjostrand C; Dahlgren A; Belin AC
• Article: EUROPEAN JOURNAL OF NEUROLOGY. 2024;31(8):e16331

  Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study

  Hallberg S; Evertsson B; Lillvall E; Boremalm M; de Flon P; Wang Y; Salzer J; Lycke J; Fink K; Frisell T; Al Nimer F; Svenningsson A
• Article: PSYCHONEUROENDOCRINOLOGY. 2024;164:107008

  A novel biomarker of interleukin 6 activity and clinical and cognitive outcomes in depression

  Foley EM; Slaney C; Donnelly NA; Kaser M; Ziegler L; Khandaker GM
• Conference publication: 2024;:83-86

  Chewing Efficiency and Oral developmental functions in Children with Oral- and Speech Motor Disorders Compared to Peers

  Björelius H; Trang J; Johansson F; Tsilingaridis G; Thorman R; Terband H
• Article: JOURNAL OF MOLECULAR NEUROSCIENCE. 2024;74(2):45

  Genetic and Phenotypic Profiling of Triptan Users in a Swedish Cluster Headache Cohort

  Olofsgard FJ; Ran C; Qin Y; Fourier C; Waldenlind E; Steinberg A; Sjostrand C; Belin AC
• Article: BMC NEUROLOGY. 2024;24(1):120

  Large variations in atrial fibrillation screening practice after ischemic stroke and transient ischemic attack in Sweden: a survey study

  Straat K; Isaksson E; Laska AC; Rooth E; Svennberg E; Asberg S; Wester P; Engdahl J
• Article: LOGOPEDICS PHONIATRICS VOCOLOGY. 2024;49(2):47-57

  Dysphagia terminology for texture modified fluid and food: a national survey of speech-language pathologists' practice

  Yli-Hukka J; Lignell J; Eriksson K; Bergstrom L
• Article: MULTIPLE SCLEROSIS JOURNAL - EXPERIMENTAL, TRANSLATIONAL AND CLINICAL. 2024;10(2):20552173241252566

  A comparative study of fatigue and processing speed in patients with multiple sclerosis treated with natalizumab or rituximab

  Hellgren J; Strandberg MC; Kallen K; Svenningsson A
• Study protocol: PLOS ONE. 2024;19(3):e0299800

  A person-centred care transition support for people with stroke/TIA: A study protocol for effect and process evaluation using a non-randomised controlled design

  Lindblom S; Flink M; von Koch L; Tistad M; Stenberg U; Elf M; Carlsson AC; Laska AC; Ytterberg C
• Article: HEALTHCARE. 2024;12(4):497

  Callers' Descriptions of Stroke Symptoms during Emergency Calls in Victims Who Have Fallen or Been Found Lying Down: A Qualitative Content Analysis

  Lindstrom V; Romanitan MO; Berglund A; Pirvulescu RA; von Euler M; Bohm K
• Article: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2024;95(2):134-141

  Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy

  Longinetti E; Englund S; Burman J; Fink K; Fogdell-Hahn A; Gunnarsson M; Hillert J; Langer-Gould AM; Lycke J; Nilsson P; Salzer J; Svenningsson A; Mellergard J; Olsson T; Piehl F; Frisell T
• Article: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2024;95(2):125-133

  Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study

  Silfverberg T; Zjukovskaja C; Ljungman P; Nahimi A; Ahlstrand E; Dreimane A; Einarsdottir S; Fagius J; Iacobaeus E; Hagglund H; Lange N; Lenhoff S; Lycke J; Mellergard J; Piehl F; Svenningsson A; Tolf A; Cherif H; Carlson K; Burman J
• Journal article: EJVES SHORT REPORTS. 2024;62:s6-s7

  Interaction Between Subclinical Carotid Atherosclerosis Endotype and Biological Sex: A Study From Improve Cohort

  Chen QS; Bergman O; Ziegler L; Baldassarre D; Tremoli E; Strawbridge R; Eriksson P; Gigante B
• Article: JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY. 2024;81:127348

  Blood lead concentrations in exposed forecourt attendants and taxi drivers in parts of South Africa

  Olowoyo JO; Tshoni UA; Kobyana AS; Lion GN; Mugivhisa LL; Koski L; Warmlander SKTS; Roos PM
• Article: CARDIOVASCULAR RESEARCH. 2023;119(16):2594-2606

  A machine learning based approach to identify carotid subclinical atherosclerosis endotypes

  Chen QS; Bergman O; Ziegler L; Baldassarre D; Veglia F; Tremoli E; Strawbridge RJ; Gallo A; Pirro M; Smit AJ; Kurl S; Savonen K; Lind L; Eriksson P; Gigante B
• Article: BMC RESEARCH NOTES. 2023;16(1):369

  Translation, and validation of Dysphagia Outcome and Severity Scale (DOSS): Swedish version

  Movander K; Palmquist TL; Hagglund P; Bergstrom L
• Article: FRONTIERS IN IMMUNOLOGY. 2023;14:1241199

  Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay

  Kmezic I; Gustafsson R; Fink K; Svenningsson A; Samuelsson K; Ingre C; Olsson T; Hansson M; Kockum I; Adzemovic MZ; Press R
• Study protocol: BMJ OPEN. 2023;13(11):e073470

  Multicentre, national, investigator-initiated, randomised, parallel-group, register-based superiority trial to compare extended ECG monitoring versus standard ECG monitoring in elderly patients with ischaemic stroke or transient ischaemic attack and the effect on stroke, death and intracerebral bleeding: the AF SPICE protocol

  Engdahl J; Straat K; Isaksson E; Rooth E; Svennberg E; Norrving B; Euler MV; Hellqvist K; Gu W; Stroem JO; Sjaelander S; Eriksson M; Asberg S; Wester P
• Journal article: BRAIN BEHAVIOR AND IMMUNITY. 2023;114:44

  A novel marker of interleukin 6 activity and clinical and cognitive outcomes in depression

  Foley EM; Slaney C; Kaser M; Ziegler L; Khandaker G
• Article: ACTA ANAESTHESIOLOGICA SCANDINAVICA. 2023;67(10):1403-1413

  High-flow via a tracheostomy tube and speaking valve during weaning from mechanical ventilation and tracheostomy

  Egbers PHH; Sutt A-L; Petersson JEE; Bergstrom L; Sundman E
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:616

  Clinical Effectiveness and Safety of Cladribine Tablets for Patients Treated at least 24 Months in the Swedish post-market surveillance study "Immunomodulation and Multiple Sclerosis Epidemiology 10"(IMSE 10)

  Larsson V; Forsberg L; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:617

  A comparison of administration and discontinuation of Natalizuamb in Sweden over time for patients treated with either sucutaneous (SC) or intravenous (IV) administration methods since July 2021

  Forsberg L; Larsson V; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:965-966

  Improved clinical outcomes in patients treated with Natalizumab for at least 11 years - Real-world data from a Swedish national post-marketing surveillance study (IMSE 1)

  Forsberg L; Larsson V; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:968-969

  CLADCOMS- CLADribine tablets long-term Control Of MS - a post-marketing investigator driven study

  Larsson V; Nilsson P; Magdalena LA; Svenningsson A; Gunnarsson M; Ayad A; Vrethem M; Burman J; Lycke J; Piehl F; Fink K
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:358-359

  Hypogammaglobulinemia during rituximab treatment in multiple sclerosis - the Hypogamma-MS study

  Hallberg S; Evertsson B; Lillvall E; Boremalm M; de Flon P; Salzer J; Lycke J; Fink K; Wang Y; Frisell T; Al Nimer F; Svenningsson A
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:617-618

  Prediction of gammaglobulin decrease during rituximab treatment in MS

  Kallin S; Hallberg S; Evertsson B; Wang Y; Fink K; Salzer J; Lycke J; Al Nimer F; Svenningsson A
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:101

  Can we reduce costs of our high efficacy MS therapies?

  Svenningsson A
• Conference publication: CEPHALALGIA. 2023;43(1supp):84

  Disease Characteristics in Triptan Users and Non-users in a Swedish Cluster Headache Cohort

  Olofsgard FJ; Ran C; Wellfelt K; Sjostrand C; Waldenlind E; Steinberg A; Belin AC
• Conference publication: CEPHALALGIA. 2023;43(1supp):100

  Actigraphy and self-assessed sleep study show increased sleep latency and sleep related stress in cluster headache

  Ran C; Olofsgard FJ; Steinberg A; Wellfelt K; Sjostrand C; Waldenlind E; Dahlgren A; Belin AC
• Article: JOURNAL OF HEADACHE AND PAIN. 2023;24(1):114

  Patients with cluster headache show signs of insomnia and sleep related stress: results from an actigraphy and self-assessed sleep study

  Ran C; Olofsgard FJ; Steinberg A; Sjoestrand C; Waldenlind E; Dahlgren A; Belin AC
• Article: ANNALS OF NEUROLOGY. 2023;94(4):713-726

  Cluster Headache Genomewide Association Study and Meta-Analysis Identifies Eight Loci and Implicates Smoking as Causal Risk Factor

  Winsvold B; Harder AVEA; Ran C; Chalmer M; Dalmasso MC; Ferkingstad E; Tripathi KP; Bacchelli E; Borte S; Fourier CS; Petersen AH; Vijfhuizen L; Magnusson S; O'Connor E; Bjornsdottir G; Happola P; Wang Y-F; Callesen I; Kelderman T; Gallardo VJ; de Boer I; Olofsgard FJ; Heinze K; Lund N; Thomas LF; Hsu C-L; Pirinen M; Hautakangas H; Ribases M; Guerzoni S; Sivakumar P; Yip J; Heinze A; Kucukali FB; Ostrowski SS; Pedersen OE; Kristoffersen ES; Martinsen AE; Artigas MS; Lagrata S; Cainazzo MM; Adebimpe J; Quinn O; Goebel CE; Cirkel A; Volk A; Heilmann-Heimbach SE; Skogholt AH; Gabrielsen ME; Wilbrink LA; Danno D; Mehta DR; Guobjartsson DF; Rosendaal FR; van Dijk KW; Fronczek RA; Wagner M; Scherer M; Goebel HA; Sleegers K; Sveinsson O; Pani L; Zoli M; Ramos-Quiroga JA; Dardiotis E; Steinberg A; Riedel-Heller S; Sjostrand C; Thorgeirsson TE; Stefansson H; Southgate L; Trembath RC; Vandrovcova J; Noordam R; Paemeleire KH; Stefansson K; Fann CS-J; Waldenlind E; Tronvik E; Jensen RH; Chen S-P; Houlden H; Terwindt GC; Kubisch C; Maestrini E; Vikelis M; Pozo-Rosich P; Belin AC; Matharu M; van den Maagdenberg AMJM; Hansen TF; Ramirez A; Zwart J-A
• Article: INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS. 2023;58(4):1017-1028

  Measuring communication as a core outcome in aphasia trials: Results of the ROMA-2 international core outcome set development meeting

  Wallace SJ; Worrall L; Rose TA; Alyahya RSW; Babbitt E; Beeke S; de Beer C; Bose A; Bowen A; Brady MC; Breitenstein C; Bruehl S; Bryant L; Cheng BBY; Cherney LR; Conroy P; Copland DA; Croteau C; Cruice M; Dipper L; Hilari K; Howe T; Kelly H; Kiran S; Laska A-C; Marshall J; Murray LL; Patterson J; Pearl G; Quinting J; Rochon E; Rose ML; Rubi-Fessen I; Sage K; Simmons-Mackie N; Visch-Brink E; Volkmer A; Webster J; Whitworth A; Dorze GL
• Review: JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY. 2023;78:127165

  Metal concentrations in cerebrospinal fluid, blood, serum, plasma, hair, and nails in amyotrophic lateral sclerosis: A systematic review and meta-analysis

  Kamalian A; Foroughmand I; Koski L; Darvish M; Saghazadeh A; Kamalian A; Razavi SZE; Abdi S; Dehgolan SR; Fotouhi A; Roos PM
• Article: JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY. 2023;78:127163

  Metal ratios as possible biomarkers for amyotrophic lateral sclerosis

  Koski L; Berntsson E; Vikstrom M; Warmlander SKTS; Roos PM
• Article: ISCIENCE. 2023;26(6):106906

  Disease phenotype prediction in multiple sclerosis

  Herman S; McShane SA; Zjukovskaja C; Khoonsari PE; Svenningsson A; Burman J; Spjuth O; Kultima K
• Journal article: ALZHEIMERS & DEMENTIA. 2023;19(S8)

  Temporal trends in the incidence of atrial fibrillation‐related strokes in Sweden, 2001‐2020

  Ding M; Wennberg AM; Ziegler LD; Modig K
• Journal article: JOURNAL OF VASCULAR SURGERY. 2023;77(6):1851

  Nationwide Outcome Analysis of Primary Carotid Endarterectomy in Symptomatic Patients Depending on Closure Technique and Patch Type

  Jonsson M; Hammar K; Lindberg M; Lundström A; Franko MA; Laska A-C; Wester P; Mani K
• Article: LANCET REGIONAL HEALTH-EUROPE. 2023;28:100596

  Time trends in atrial fibrillation-related stroke during 2001-2020 in Sweden: a nationwide, observational study

  Ding M; Ebeling M; Ziegler L; Wennberg A; Modig K
• Article: DYSPHAGIA. 2023;38(2):667-675

  How Valid and Reliable Is the International Dysphagia Diet Standardisation Initiative (IDDSI) When Translated into Another Language?

  Dahlstrom S; Henning I; McGreevy J; Bergstrom L
• Article: EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. 2023;65(4):467-473

  Nationwide Outcome Analysis of Primary Carotid Endarterectomy in Symptomatic Patients Depending on Closure Technique and Patch Type

  Jonsson M; Hammar K; Lindberg M; Lundstrom A; Franko MA; Laska A-C; Wester P; Mani K
• Article: NEUROLOGY. 2023;100(12):e1207-e1220

  Sex Differences in Clinical Features, Treatment, and Lifestyle Factors in Patients With Cluster Headache

  Fourier C; Ran C; Steinberg A; Sjoestrand C; Waldenlind E; Belin AC
• Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023;24(6):5950

  Investigating Vitamin D Receptor Genetic Markers in a Cluster Headache Meta-Analysis

  Jennysdotter Olofsgard F; Ran C; Qin Y; Fourier C; Sjoestrand C; Waldenlind E; Steinberg A; Belin AC
• Article: NEUROLOGY. 2023;100(10):e1083-e1094

  Multimorbidity and Sickness Absence/Disability Pension in Patients With Cluster Headache and Matched References A Swedish Register-Based Study

  Ran C; Alexanderson K; Belin AC; Almondo G; Steinberg A; Sjoestrand C
• Review: DYSPHAGIA. 2023;38(1):76-121

  Prevalence of Oropharyngeal Dysphagia in Adults in Different Healthcare Settings: A Systematic Review and Meta-analyses

  Rivelsrud MC; Hartelius L; Bergstrom L; Lovstad M; Speyer R
• Article: DYSPHAGIA. 2023;38(1):305-314

  Dysphagia Management and Cervical Auscultation: Reliability and Validity Against FEES

  Jaghbeer M; Sutt A-L; Bergstrom L
• Article: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2023;70:104481

  Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort

  Englund S; Kierkegaard M; Burman J; Fink K; Fogdell-Hahn A; Gunnarsson M; Hillert J; Langer-Gould A; Lycke J; Nilsson P; Salzer J; Svenningsson A; Mellergard J; Olsson T; Longinetti E; Frisell T; Piehl F
• Article: LANCET NEUROLOGY. 2023;22(2):117-126

  Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial

  Roaldsen MB; Eltoft A; Wilsgaard T; Christensen H; Engelter ST; Indredavik B; Jatuzis D; Karelis G; Korv J; Lundstrom E; Petersson J; Putaala J; Soyland M-H; Tveiten A; Bivard A; Johnsen SH; Mazya MV; Werring DJ; Wu TY; De Marchis GM; Robinson TG; Mathiesen EB
• Article: HEALTHCARE. 2023;11(3):391

  The Use of Teach Back at Hospital Discharge to Support Self-Management of Prescribed Medication for Secondary Prevention after Stroke-Findings from A Feasibility Study

  Lindblom S; Ytterberg C; Flink M; Carlsson ACC; Stenberg U; Tistad M; von Koch L; Laska AC
• Article: BMJ NEUROLOGY OPEN. 2023;5(1):e000423

  Effects of blood pressure and tranexamic acid in spontaneous intracerebral haemorrhage: a secondary analysis of a large randomised controlled trial

  Appleton JP; Law ZK; Woodhouse LJ; Salman RA-S; Beridze M; Christensen H; Dineen RA; Guerrero JJE; England TJ; Karlinski M; Krishnan K; Laska AC; Lyrer P; Ozturk S; Roffe C; Roberts I; Robinson TG; Scutt P; Werring DJ; Bath PM; Sprigg N
• Article: THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. 2023;16:17562864231168278

  Impact of prehospital stroke triage implementation on patients with intracerebral hemorrhage

  Almqvist T; Falk Delgado A; Sjoestrand C; Ahmed N; Berglund A; Eriksson E; Mazya MV
• Journal article: NEUROSCIENCE APPLIED. 2023;2:102449

  A novel marker of interleukin 6 activity and clinical and cognitive outcomes in depression

  Foley ÉM; Slaney C; Kaser M; Barnes NM; Ziegler L; Khandaker GM
• Article: BRAIN COMMUNICATIONS. 2022;5(1):fcad011

  Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosis

  Burman J; Zjukovskaja C; Svenningsson A; Freyhult E; Wiberg A; Kultima K
• Conference publication: JOURNAL OF HEADACHE AND PAIN. 2022;23(SUPPL 1)

  Cluster headache genome-wide association study identifies seven loci and implicates smoking as causal risk factor

  Winsvold BS; Harder A; Ran C; Chalmer MA; Dalmasso MC; Ferkingstad E; Belin A; Matharu M; Van den Maagdenberg A; Hansen TF; Ramirez A; Zwart JA
• Article: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2022;68:104220

  Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosis

  Tedeholm H; Piehl F; Lycke J; Link J; Stawiarz L; Burman J; de Flon P; Fink K; Gunnarsson M; Mellergard J; Nilsson P; Sundstrom P; Svenningsson A; Johansson H; Andersen O
• Review: INTERNATIONAL JOURNAL OF STROKE. 2022;17(10):1067-1077

  Precision rehabilitation for aphasia by patient age, sex, aphasia severity, and time since stroke? A prespecified, systematic review-based, individual participant data, network, subgroup meta-analysis

  Brady MC; Ali M; VandenBerg K; Williams LJ; Williams LR; Abo M; Becker F; Bowen A; Brandenburg C; Breitenstein C; Bruehl S; Copland DA; Cranfill TB; Di Pietro-Bachmann M; Enderby P; Fillingham J; Galli FL; Gandolfi M; Glize B; Godecke E; Hawkins N; Hilari K; Hinckley J; Horton S; Howard D; Jaecks P; Jefferies E; Jesus LMT; Kambanaros M; Kang EK; Khedr EM; Kong AP-H; Kukkonen T; Laganaro M; Ralph MAL; Laska AC; Leemann B; Leff AP; Lima RR; Lorenz A; MacWhinney B; Marshall RS; Mattioli F; Mavis I; Meinzer M; Nilipour R; Noe E; Paik N-J; Palmer R; Papathanasiou I; Patricio B; Martins IP; Price C; Jakovac TP; Rochon E; Rose ML; Rosso C; Rubi-Fessen I; Ruiter MB; Snell C; Stahl B; Szaflarski JP; Thomas SA; van de Sandt-Koenderman M; van der Meulen I; Visch-Brink E; Worrall L; Wright HH
• Article: CYTOKINE. 2022;159:156020

  IL-6 signalling biomarkers in hospitalised patients with moderate to severe SARS-CoV-2 infection in a single centre study in Sweden

  Ziegler L; Lundstrom A; Havervall S; Thalin C; Gigante B
• Article: CIRCULATION. 2022;146(14):1056-1066

  Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study

  Oldgren J; Asberg S; Hijazi Z; Wester P; Bertilsson M; Norrving B
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(3_SUPPL):515-516

  SARS-COV2 exposure rates and serological response of people living with MS

  Longinetti E; Hogelin KA; Kockum I; Englund S; Burman J; Fink K; Fogdell-Hahn A; Gunnarsson M; Hillert J; Nilsson P; Langer-Gould A; Lycke J; Nilsson P; Salzer J; Svenningsson A; Mellergard J; Frisell T; Olsson T; Piehl F
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(3_SUPPL):858-859

  Clinical effectiveness and safety of dimethyl fumarate for patients treated at least 6 years in the swedish post-market surveillance study "immunomodulation and multiple sclerosis epidemiology 5" (IMSE 5)

  Forsberg L; Ekstrom E; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Lantblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(3_SUPPL):352-353

  Improved clinical outcomes in patients treated with natalizumab for at least 11 years - real-world data from a swedish national post-marketing surveillance study (IMSE 1)

  Forsberg L; Ekstrom E; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(3_SUPPL):638-639

  Clinical effectiveness and safety of cladribine tablets for patients treated at least 12 months in the Swedish post-market surveillance study "immunomodulation and multiple sclerosis epidemiology 10" (IMSE 10)

  Rosengren V; Forsberg L; Ekstrom E; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Article: JOURNAL OF STROKE & CEREBROVASCULAR DISEASES. 2022;31(10):106686

  Maintained acute stroke admission during the first wave COVID-19 pandemic in Sweden, a register-based study

  Rydell M; Wester P; Laska A-C; Rudberg A-S
• Article: BMJ CASE REPORTS. 2022;15(9):e249156

  Cerebral microvascular injuries in severe COVID-19 infection: progression of white matter hyperintensities post-infection

  Petersson I; Hansen BM; Svenningsson A; Lundstrom A
• Corrigendum: BMC NEUROLOGY. 2022;22(1):337

  IL6 trans-signaling associates with ischemic stroke but not with atrial fibrillation (vol 21, 306, 2021)

  Ziegler L; Wallen H; Aspberg S; de Faire U; Gigante B
• Conference publication: CEPHALALGIA. 2022;42(1_SUPPL):11-12

  Investigating the Impact of Genetic Variants on Triptan Response in Cluster Headache

  Olofsgard FMEJ; Ran C; Qin Y; Fourier C; Sjostrand C; Waldenlind E; Steinberg A; Belin AC
• Editorial: STROKE. 2022;53(9):E426-E428

  Selective Serotonin Reuptake Inhibitors for Stroke Recovery

  Hua X; Wu S; Legg LA; Rudberg A-S; Hackett ML; Tilney R; Lindgren L; Kutlubaev MA; Hsieh C-F; Barugh AJ; Hankey GJ; Lundstrom E; Dennis M; Mead GE
• Article: ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY. 2022;9(9):1449-1458

  COVID-19 clinical outcomes and DMT of MS patients and population-based controls

  Longinetti E; Bower H; McKay KA; Englund S; Burman J; Fink K; Fogdell-Hahn A; Gunnarsson M; Hillert J; Langer-Gould A; Lycke J; Nilsson P; Salzer J; Svenningsson A; Mellergard J; Olsson T; Piehl F; Frisell T
• Article: FRONTIERS IN NEUROLOGY. 2022;13:939618

  Prehospital stroke mimics in the Stockholm Stroke Triage System

  Sjoo M; Berglund A; Sjostrand C; Eriksson EE; Mazya MV
• Article: LANCET NEUROLOGY. 2022;21(8):693-703

  Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial

  Svenningsson A; Frisell T; Burman J; Salzer J; Fink K; Hallberg S; Hambraeus J; Axelsson M; Al Nimer F; Sundstrom P; Gunnarsson M; Johansson R; Mellergard J; Rosenstein I; Ayad A; Sjoblom I; Risedal A; de Flon P; Gilland E; Lindeberg J; Shawket F; Piehl F; Lycke J
• Article: LOGOPEDICS PHONIATRICS VOCOLOGY. 2022;47(3):146-156

  Tracheostomy management by speech-language pathologists in Sweden

  Wiberg S; Whitling S; Bergstrom L
• Editorial: MULTIPLE SCLEROSIS JOURNAL. 2022;28(8):1177-1178

  Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: Commentary

  Lycke J; Svenningsson A
• Editorial: JOURNAL OF CLINICAL MEDICINE. 2022;11(12):3403

  Reply to Dziewas, R.; Bath, PM Endpoints in Dysphagia Trials. Comment on "Speyer et al. Neurostimulation in People with Oropharyngeal Dysphagia: A Systematic Review and Meta-Analyses of Randomised Controlled Trials-Part I: Pharyngeal and Neuromuscular Electrical Stimulation. J. Clin. Med. 2022, 11, 776"

  Speyer R; Sutt A-L; Bergstrom L; Hamdy S; Heijnen BJ; Remijn L; Wilkes-Gillan S; Cordier R
• Article: EUROPEAN STROKE JOURNAL. 2022;7(2):126-133

  Analysis and modelling of mistriage in the Stockholm stroke triage system

  Keselman B; Berglund A; Ahmed N; Grannas D; von Euler M; Holmin S; Laska A-C; Mathe JM; Sjostrand C; Eriksson EE; Mazya MV
• Article: BMC HEALTH SERVICES RESEARCH. 2022;22(1):594

  Referral-based transition to subsequent rehabilitation at home after stroke: one-year outcomes and use of healthcare services

  Lindblom S; Tistad M; Flink M; Laska AC; von Koch L; Ytterberg C
• Article: APHASIOLOGY. 2022;36(4):555-574

  An aphasia research agenda - a consensus statement from the collaboration of aphasia trialists

  Ali M; Soroli E; Jesus LMT; Cruice M; Isaksen J; Visch-Brink E; Grohmann KK; Jagoe C; Kukkonen T; Varlokosta S; Hernandez-Sacristan C; Rosell-Clari V; Palmer R; Martinez-Ferreiro S; Godecke E; Wallace SJ; McMenamin R; Copland D; Breitenstein C; Bowen A; Laska A-C; Hilari K; Brady MC
• Article: APHASIOLOGY. 2022;36(4):513-533

  Utilising a systematic review-based approach to create a database of individual participant data for meta- and network meta-analyses: the RELEASE database of aphasia after stroke

  Williams LR; Ali M; VandenBerg K; Williams LJ; Abo M; Becker F; Bowen A; Brandenburg C; Breitenstein C; Bruehl S; Copland DA; Cranfill TB; Di Pietro-Bachmann M; Enderby P; Fillingham J; Galli FL; Gandolfi M; Glize B; Godecke E; Hawkins N; Hilari K; Hinckley J; Horton S; Howard D; Jaecks P; Jefferies E; Jesus LMT; Kambanaros M; Kang EK; Khedr EM; Kong AP-H; Kukkonen T; Laganaro M; Ralph MAL; Laska AC; Leemann B; Leff AP; Lima RR; Lorenz A; MacWhinney B; Marshall RS; Mattioli F; Mavis I; Meinzer M; Nilipour R; Noe E; Paik N-J; Palmer R; Papathanasiou I; Patricio BF; Martins IP; Price C; Jakovac TP; Rochon E; Rose ML; Rosso C; Rubi-Fessen I; Ruiter MB; Snell C; Stahl B; Szaflarski JP; Thomas SA; Van de Sandt-Koenderman M; Van der Meulen I; Visch-Brink E; Worrall L; Wright HH; Brady MC
• Article: APHASIOLOGY. 2022;36(4):534-554

  Protocol for the development of the international population registry for aphasia after stroke (I-PRAISE)

  Ali M; Ben Basat AL; Berthier M; Blom Johansson M; Breitenstein C; Cadilhac DA; Constantinidou F; Cruice M; Davila G; Gandolfi M; Gil M; Grima R; Godecke E; Jesus L; Jiminez LM; Kambanaros M; Kukkonen T; Laska A; Mavis I; Mc Menamin R; Mendez-Orellana C; Obrig H; Ostberg P; Robson H; Sage K; Van De Sandt-koenderman M; Sprecht K; Visch-Brink E; Wehling E; Wielaert S; Wallace SJ; Williams LJ; Brady MC
• Article: STROKE. 2022;53(4):1141-1148

  Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial

  Law ZK; Appleton JP; Scutt P; Roberts I; Salman RA-S; England TJ; Werring DJ; Robinson T; Krishnan K; Dineen RA; Laska AC; Lyrer PA; Egea-Guerrero JJ; Karlinski M; Christensen H; Roffe C; Bereczki D; Ozturk S; Thanabalan J; Collins R; Beridze M; Ciccone A; Duley L; Shone A; Bath PM; Sprigg N
• Article: CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. 2022;99(5):1551-1557

  Atrial fibrillation after closure of patent foramen ovale in the REDUCE clinical study

  Andersen A; Matzen KL; Andersen G; Settergren M; Sjostrand C; Iversen HK; Roine RO; Hildick-Smith D; Spence JD; Rhodes JF; Kasner SE; Sondergaard L; Nielsen-Kudsk JE
• Article: DISABILITY AND REHABILITATION. 2022;44(7):1098-1106

  The physical environment and multi-professional teamwork in three newly built stroke units

  Anaker A; von Koch L; Eriksson G; Sjostrand C; Elf M
• Article: EUROPEAN STROKE JOURNAL. 2022;7(1):41-47

  Mechanical thrombectomy in stroke patients of working age: Real-world outcomes in Sweden

  Roland M; Markaki I; Andersson T; Arnberg F; Sjostrand C
• Review: STROKE. 2022;53(3):956-967

  Dosage, Intensity, and Frequency of Language Therapy for Aphasia: A Systematic Review-Based, Individual Participant Data Network Meta-Analysis

  Brady MC; Ali M; VandenBerg K; Williams LJ; Williams LR; Abo M; Becker F; Bowen A; Branden-burg C; Breitenstein C; Bruehl S; Copland DA; Cranfill TB; Di Pietro-Bachmann M; Enderby P; Fillingham J; Galli FL; Gandolfi M; Glize B; Godecke E; Hawkins N; Hilari K; Hinckley J; Horton S; Howard D; Jaecks P; Jefferies E; Jesus LMT; Kambanaros M; Kang EK; Khedr EM; Kong AP-H; Kukkonen T; Laganaro M; Ralph MAL; Laska AC; Leemann B; Leff AP; Lima RR; Lorenz A; MacWhinney B; Marshall RS; Mattioli F; MaviS I; Meinzer M; Nilipour R; Noe E; Paik N-J; Palmer R; Papathanasiou I; Patricio B; Martins IP; Price C; Jakovac TP; Rochon E; Rose ML; Rosso C; Rubi-Fessen I; Ruiter MB; Snell C; Stahl B; Szaf-larski JP; Thomas SA; Van de Sandt-Koenderman M; van der Meulen I; Visch-Brink E; Worrall L; Wright HH
• Review: JOURNAL OF CLINICAL MEDICINE. 2022;11(4):993

  Neurostimulation in People with Oropharyngeal Dysphagia: A Systematic Review and Meta-Analysis of Randomised Controlled Trials-Part II: Brain Neurostimulation

  Speyer R; Sutt A-L; Bergstroem L; Hamdy S; Pommee T; Balaguer M; Kaale A; Cordier R
• Article: ECLINICALMEDICINE. 2022;44:101274

  Effect of continuing versus stopping pre-stroke antihypertensive agents within 12 h on outcome after stroke: A subgroup analysis of the efficacy of nitric oxide in stroke (ENOS) trial

  Woodhouse LJ; Appleton JP; Scutt P; Everton L; Wilkinson G; Caso V; Czlonkowska A; Gommans J; Krishnan K; Laska AC; Ntaios G; Ozturk S; Phillips S; Pocock S; Prasad K; Szatmari S; Wardlaw JM; Sprigg N; Bath PM
• Review: EUROPEAN CARDIOLOGY. 2022;17:e09

  Circulating Biomarkers in Lower Extremity Artery Disease

  Ziegler L; Hedin U; Gottsater A
• Journal article: JOURNAL OF VASCULAR SURGERY. 2022;75(2):765

  Low Incidence of Late Ipsilateral Ischaemic Stroke After Treatment for Symptomatic Carotid Stenosis in Sweden 2008–2017: Increased Risk in the Elderly and After Carotid Stenting

  Hammar K; Laska AC; Wester P; Mani K; Lundström A; Jonsson M
• Article: STROKE. 2022;53(2):473-481

  The Stockholm Stroke Triage Project Outcomes of Endovascular Thrombectomy Before and After Triage Implementation

  Keselman B; Berglund A; Ahmed N; Bottai M; von Euler M; Holmin S; Laska A-C; Mathe JM; Sjostrand C; Eriksson EE; Mazya MV
• Review: JOURNAL OF CLINICAL MEDICINE. 2022;11(3):776

  Neurostimulation in People with Oropharyngeal Dysphagia: A Systematic Review and Meta-Analyses of Randomised Controlled Trials-Part I: Pharyngeal and Neuromuscular Electrical Stimulation

  Speyer R; Sutt A-L; Bergstrom L; Hamdy S; Heijnen BJ; Remijn L; Wilkes-Gillan S; Cordier R
• Review: JOURNAL OF CLINICAL MEDICINE. 2022;11(3):685

  Behavioural Interventions in People with Oropharyngeal Dysphagia: A Systematic Review and Meta-Analysis of Randomised Clinical Trials

  Speyer R; Cordier R; Sutt A-L; Remijn L; Heijnen BJ; Balaguer M; Pommee T; McInerney M; Bergstrom L
• Article: PLOS ONE. 2022;17(1):e0262169

  SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection

  Havervall S; Falk AJ; Klingstrom J; Ng H; Greilert-Norin N; Gabrielsson L; Salomonsson A-C; Isaksson E; Rudberg A-S; Hellstrom C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Christ W; Olausson M; Hedhammar M; Tegel H; Mangsbo S; Phillipson M; Manberg A; Hober S; Nilsson P; Thalin C
• Article: INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY. 2022;24(1):77-87

  Dysphagia management: Does structured training improve the validity and reliability of cervical auscultation?

  Bergstrom L; Cichero JAY
• Preprint: SSRN ELECTRONIC JOURNAL. 2022

  Time Trends in Atrial Fibrillation-Related Stroke in an Era of Declining Stroke - A Swedish Nationwide Register-Based Study

  Ding M; Ebeling M; Ziegler L; Wennberg A; Modig K
• Editorial: FRONTIERS IN CARDIOVASCULAR MEDICINE. 2022;9:912472

  Editorial: Platelet Function in COVID-19.

  Lundström A; Sandén P; Mitroulis I; van der Meijden PEJ
• Article: EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. 2022;63(1):24-32

  Low Incidence of Late Ipsilateral Ischaemic Stroke After Treatment for Symptomatic Carotid Stenosis in Sweden 2008-2017: Increased Risk in the Elderly and After Carotid Stenting

  Hammar K; Laska AC; Wester P; Mani K; Lundstrom A; Jonsson M
• Article: BMJ OPEN. 2021;11(12):e047329

  Person-centred care transitions for people with stroke: study protocol for a feasibility evaluation of codesigned care transition support

  Flink M; Lindblom S; Tistad M; Laska AC; Bertilsson BC; Warlinge C; Hasselstrom J; Elf M; von Koch L; Ytterberg C
• Letter: THROMBOSIS AND HAEMOSTASIS. 2021;121(12):1668-1669

  COVID-19 is Associated with an Acquired Factor XIII Deficiency

  von Meijenfeldt FA; Havervall S; Adelmeijer J; Lundstrom A; Magnusson M; Mackman N; Thalin C; Lisman T
• Article: FRONTIERS IN NEUROLOGY. 2021;12:765296

  Sex Equitable Prehospital Stroke Triage Using Symptom Severity and Teleconsultation

  Wiebert E; Berglund A; Sjoestrand C; Eriksson EE; Mazya MV
• Article: FRONTIERS IN NEUROLOGY. 2021;12:741551

  Staff and Facility Utilization in Direct Patient Transfer to the Comprehensive Stroke Center: Testing a Real-Time Location System for Automatic Patient Pathway Characterization

  Moreira T; Furnica A; Daemen E; Mazya MV; Sjoestrand C; Kaijser M; van Loenen E
• Review: COCHRANE DATABASE OF SYSTEMATIC REVIEWS. 2021;11(11):CD009286

  Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery

  Legg LA; Tilney R; Hsieh C-F; Wu S; Lundstrom E; Rudberg A-S; Kutlubaev MA; Dennis M; Barugh A; Hackett ML; Hankey GJ; Mead GE
• Review: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021;22(22):12193

  Metals in ALS TDP-43 Pathology

  Koski L; Ronnevi C; Berntsson E; Warmlander SKTS; Roos PM
• Article: STROKE. 2021;52(11):3419-3426

  Patent Foramen Ovale Closure Decreases the Incidence but Not the Size of New Brain Infarction on Magnetic Resonance Imaging An Analysis of the REDUCE Trial

  Messe SR; Erus G; Bilello M; Davatzikos C; Andersen G; Iversen HK; Roine RO; Sjostrand C; Rhodes JF; Sondergaard L; Kasner SE
• Article: JAMA NETWORK OPEN. 2021;4(11):e2132376

  Assessment of Discrepancies Between Follow-up Infarct Volume and 90-Day Outcomes Among Patients With Ischemic Stroke Who Received Endovascular Therapy

  Ganesh A; Ospel JM; Menon BK; Demchuk AM; McTaggart RA; Nogueira RG; Poppe AY; Almekhlafi MA; Hanel RA; Thomalla G; Holmin S; Puetz V; van Adel BA; Tarpley JW; Tymianski M; Hill MD; Goyal M
• Article: CEPHALALGIA. 2021;41(13):1374-1381

  The molecular clock gene cryptochrome 1 (CRY1) and its role in cluster headache

  Fourier C; Ran C; Sjostrand C; Waldenlind E; Steinberg A; Belin AC
• Journal article: EUROPEAN HEART JOURNAL. 2021;42(Supplement_1):ehab724.2510

  IL6 trans-signalling is associated with a higher risk of cardiovascular events in individuals with diabetes

  Ziegler L; Gigante B
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2021;27(2_SUPPL):21-22

  Effectiveness of initial MS treatments in the COMBAT-MS trial: injectables, dimethyl fumarate, natalizumab and rituximab

  Alping P; Burman J; Fink K; Fogdell-Hahn A; Gunnarsson M; Hillert J; Langer-Gould A; Lycke J; Nilsson P; Olsson T; Salzer J; Svenningsson A; Vrethem M; Frisell T; Piehl F
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2021;27(2_SUPPL):677-678

  Trajectories of processing speed, disability, and their connections, over the years following disease modulatory treatment initiation among relapsing-remitting multiple sclerosis patients

  Longinetti E; Englund S; Burman J; Fogdell-Hahn A; Gunnarsson M; Hillert J; Langer-Gould A; Lycke J; Nilsson P; Salzer J; Svenningsson A; Vrethem M; Olsson T; Piehl F; Frisell T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2021;27(2_SUPPL):671-672

  The effect of different national treatment strategies on disability outcome in relapsing-remitting multiple sclerosis: a propensity score adjusted comparison between Denmark and Sweden

  Spelman T; Magyari M; Piehl F; Svenningsson A; Rasmussen PV; Kant M; Sellebjerg F; Joensen H; Hillert J; Lycke J
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2021;27(2_SUPPL):615-616

  Clinical effectiveness and safety of dimethyl fumarate for patients treated at least 5 years in the Swedish post-market surveillance study "Immunomodulation and Multiple Sclerosis Epidemiology 5" (IMSE 5)

  Rosengren V; Ekstrom E; Forsberg L; Kagstrom S; Berglund A; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2021;27(2_SUPPL):618-619

  The long-term safety and effectiveness of natalizumab (IMSE 1) - Real-world data from a Swedish nationwide pharmaco-epidemiological study

  Ekstrom E; Rosengren V; Kagstrom S; Forsberg L; Berglund A; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2021;27(2_SUPPL):623-624

  Clinical effectiveness and safety of cladribine tablets for patients treated at least 12 months in the swedish post-market surveillance study "immunomodulation and multiple sclerosis epidemiology 10" (IMSE 10)

  Rosengren V; Ekstrom E; Forsberg L; Kagstrom S; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2021;27(2_SUPPL):612-613

  Clinical effectiveness and safety of teriflunomide for patients treated at least 48 months in the Swedish post-market surveillance study "Immunomodulation and Multiple Sclerosis Epidemiology 4" (IMSE 4)

  Rosengren V; Ekstrom E; Forsberg L; Kagstrom S; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: EUROPEAN HEART JOURNAL. 2021;42:2510

  IL6 trans-signalling is associated with a higher risk of cardiovascular events in individuals with diabetes

  Ziegler L; Gigante B
• Article: JOURNAL OF MEDICAL VIROLOGY. 2021;93(10):5908-5916

  Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers

  Lundstrom A; Ziegler L; Havervall S; Rudberg A-S; von Meijenfeldt F; Lisman T; Mackman N; Sanden P; Thalin C
• Article: OPEN HEART. 2021;8(2):e001694

  Interleukin 6 trans-signalling and the risk of future cardiovascular events in men and women

  Miri Y; Leander K; Eriksson P; Gigante B; Ziegler L
• Article: STROKE. 2021;52(10):3082-3087

  Effects of Fluoxetine on Outcomes at 12 Months After Acute Stroke Results From EFFECTS, a Randomized Controlled Trial

  Lundstrom E; Isaksson E; Greilert Norin N; Nasman P; Wester P; Martensson B; Norrving B; Wallen H; Borg J; Hankey GJ; Hackett ML; Mead GE; Dennis MS; Sunnerhagen KS
• Article: JAMA NEUROLOGY. 2021;78(10):1197-1204

  Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis Data From 2 Different National Strategies

  Spelman T; Magyari M; Piehl F; Svenningsson A; Rasmussen PV; Kant M; Sellebjerg F; Joensen H; Hillert J; Lycke J
• Conference publication: JOURNAL OF HEADACHE AND PAIN. 2021;22(SUPPL 1):25

  Sleep assessment in patients with Cluster headache - self reported vs observed data

  Ran C; Fourier C; Olofsgard FJ; Wirth C; Steinberg A; Sjostrand C; Waldenlind E; Dahlgren A; Belin AC
• Conference publication: CEPHALALGIA. 2021;41(1_SUPPL):38

  Sleep assessment in patients with Cluster headache - self reported vs observed data

  Ran C; Fourier C; Olofsgard FJ; Wirth C; Steinberg A; Sjostrand C; Waldenlind E; Dahlgren A; Belin AC
• Article: BRAIN SCIENCES. 2021;11(8):1108

  PER Gene Family Polymorphisms in Relation to Cluster Headache and Circadian Rhythm in Sweden

  Olofsgard FJ; Ran C; Fourier C; Wirth C; Sjostrand C; Waldenlind E; Steinberg A; Belin AC
• Article: BMC NEUROLOGY. 2021;21(1):306

  IL6 trans-signaling associates with ischemic stroke but not with atrial fibrillation

  Ziegler L; Wallen H; Aspberg S; de Faire U; Gigante B
• Article: ANNALS OF NEUROLOGY. 2021;90(2):193-202

  Genome-Wide Association Study Identifies Risk Loci for Cluster Headache

  O'Connor E; Fourier C; Ran C; Sivakumar P; Liesecke F; Southgate L; Harder AVE; Vijfhuizen LS; Yip J; Giffin N; Silver N; Ahmed F; Hostettler IC; Davies B; Cader MZ; Simpson BS; Sullivan R; Efthymiou S; Adebimpe J; Quinn O; Campbell C; Cavalleri GL; Vikelis M; Kelderman T; Paemeleire K; Kilbride E; Grangeon L; Lagrata S; Danno D; Trembath R; Wood NW; Kockum I; Winsvold BS; Steinberg A; Sjostrand C; Waldenlind E; Vandrovcova J; Houlden H; Matharu M; Belin AC
• Editorial: NEUROLOGY. 2021;96(23):1067-1068

  Perinatal Depression and Anxiety in Multiple Sclerosis Treatable Distress

  Leavitt VM; Dobson R; Svennigsson A
• Article: NEUROLOGY-GENETICS. 2021;7(3):e584

  Novel Cysteine-Sparing Hypomorphic NOTCH3 A1604T Mutation Observed in a Family With Migraine and White Matter Lesions

  Arnardottir S; Del Gaudio F; Klironomos S; Braune E-B; Lombrana AA; Oliveira DV; Jin S; Karlstrom H; Lendahl U; Sjostrand C
• Article: HEALTH EXPECTATIONS. 2021;24(3):905-916

  The manifestation of participation within a co-design process involving patients, significant others and health-care professionals

  Lindblom S; Flink M; Elf M; Laska AC; von Koch L; Ytterberg C
• Article: THROMBOSIS AND HAEMOSTASIS. 2021;121(05):584-593

  High Thrombin Generation after Acute Ischemic Stroke or Transient Ischemic Attack Is Associated with a Reduced Risk of Recurrence: An Observational Cohort Study

  Lundstrom A; Anggardh-Rooth E; Mobarrez F; Thalin C; Gigante B; Laska AC; Wallen H
• Article: STROKE. 2021;52(5):1778-1787

  Predictors of Poststroke Aphasia Recovery A Systematic Review-Informed Individual Participant Data Meta-Analysis

  Ali M; VandenBerg K; Williams LJ; Williams LR; Abo M; Becker F; Bowen A; Brandenburg C; Breitenstein C; Bruehl S; Copland DA; Cranfill TB; Di Pietro-Bachmann M; Enderby P; Fillingham J; Galli FL; Gandolfi M; Glize B; Godecke E; Hawkins N; Hilari K; Hinckley J; Horton S; Howard D; Jaecks P; Jefferies E; Jesus LMT; Kambanaros M; Kang EK; Khedr EM; Kong AP-H; Kukkonen T; Laganaro M; Ralph MAL; Laska AC; Leemann B; Leff AP; Lima RR; Lorenz A; Mac Whinney B; Marshall RS; Meinzer M; Nilipour R; Noe E; Paik N-J; Palmer R; Papathanasiou I; Patricio BF; Martins IP; Price C; Jakovac TP; Rochon E; Rose ML; Rosso C; Rubi-Fessen I; Ruiter MB; Snell C; Stahl B; Szaflarski JP; Thomas SA; Van De Sandt-Koenderman M; van der Meulen I; Visch-Brink E; Worrall L; Wright HH; Brady MC
• Article: ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION. 2021;102(5):835-842

  A Consensus Statement for the Management and Rehabilitation of Communication and Swallowing Function in the ICU: A Global Response to COVID-19

  Freeman-Sanderson A; Ward EC; Miles A; Netto IDP; Duncan S; Inamoto Y; McRae J; Pillay N; Skoretz SA; Walshe M; Brodsky MB
• Doctoral thesis: 2021

  Long-term aspects of stroke : survival, health-related quality of life and costs

  Rudberg A-S
• Preprint: RESEARCH SQUARE. 2021

  Enhancing Recruitment Using Teleconference and Commitment Contract (ERUTECC): a stepped wedge cluster randomised trial within the EFFECTS trial

  Isaksson E; Näsman P; Wester P; Laska A-C; Lundström E
• Letter: AMERICAN JOURNAL OF HEMATOLOGY. 2021;96(4):E98-E100

  Elevated factor V activity and antigen levels in patients with Covid-19 are related to disease severity and 30-day mortality

  von Meijenfeldt FA; Havervall S; Adelmeijer J; Lundstrom A; Magnusson M; Mackman N; Thalin C; Lisman T
• Article: JOURNAL OF NEUROVIROLOGY. 2021;27(2):345-347

  Expanding the etiologic spectrum of spastic ataxia syndrome: chronic infection with human T lymphotropic virus type 1

  Af Edhom K; Lidman C; Granberg T; Taylor GP; Paucar M
• Article: STROKE. 2021;52(4):1441-1445

  Prehospital Triage Accuracy in Patients With Stroke Symptoms Assessed Within 6 to 24 Hours or With an Unknown Time of Onset

  Almqvist T; Berglund A; Sjostrand C; Eriksson E; Mazya MV
• Letter: NEW ENGLAND JOURNAL OF MEDICINE. 2021;384(10):970-971

  Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke

  Kasner SE; Rhodes JF; Andersen G; Iversen HK; Nielsen-Kudsk JE; Settergren M; Sjostrand C; Roine RO; Hildick-Smith D; Spence JD; Sondergaard L
• Preprint: MEDRXIV. 2021

  Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers

  Lundström A; Ziegler L; Havervall S; Rudberg A-S; von Meijenfeldt F; Lisman T; Mackman N; Sandén P; Thålin C
• Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2021;10(5):e019130

  Outcomes in Antiplatelet-Associated Intracerebral Hemorrhage in the TICH-2 Randomized Controlled Trial

  Law ZK; Desborough M; Roberts I; Salman RA-S; England TJ; Werring DJ; Robinson T; Krishnan K; Dineen R; Laska AC; Peters N; Egea-Guerrero JJ; Karlinski M; Christensen H; Roffe C; Bereczki D; Ozturk S; Thanabalan J; Collins R; Beridze M; Bath PM; Sprigg N
• Doctoral thesis: 2021

  Recruitment to multicentre randomised controlled trials in stroke : lessons learnt from the effects trial

  Isaksson E
• Article: METABOLITES. 2021;11(2):126

  Metabolomics of Cerebrospinal Fluid from Healthy Subjects Reveal Metabolites Associated with Ageing

  Carlsson H; Rollborn N; Herman S; Freyhult E; Svenningsson A; Burman J; Kultima K
• Article: TOPICS IN STROKE REHABILITATION. 2021;28(2):153-158

  Stroke survivors' priorities for research related to life after stroke

  Rudberg A-S; Berge E; Laska A-C; Jutterstrom S; Nasman P; Sunnerhagen KS; Lundstrom E
• Letter: BLOOD ADVANCES. 2021;5(3):756-759

  Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge

  von Meijenfeldt FA; Havervall S; Adelmeijer J; Lundstrom A; Magnusson M; Mackman N; Thalin C; Lisman T
• Article: JOURNAL OF NEUROLOGY. 2021;268(2):651-657

  Intrathecal treatment trial of rituximab in progressive MS: results after a 2-year extension

  Bergman J; Burman J; Bergenheim T; Svenningsson A
• Article: VASCULAR MEDICINE. 2021;26(1):3-10

  Expression of Interleukin 6 signaling receptors in carotid atherosclerosis

  Ziegler L; Lundqvist J; Dreij K; Wallen H; de Faire U; Paulsson-Berne G; Hedin U; Matic L; Gigante B
• Preprint: MEDRXIV. 2021

  SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection

  Havervall S; Falk AJ; Klingström J; Ng H; Greilert-Norin N; Gabrielsson L; Salomonsson A-C; Isaksson E; Rudberg A-S; Hellström C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Christ W; Olausson M; Hedhammar M; Tegel H; Mangsbo S; Phillipson M; Månberg A; Hober S; Nilsson P; Thålin C
• Preprint: SSRN ELECTRONIC JOURNAL. 2021

  The Effect of Different National Treatment Strategies on Disability Outcome in Relapsing-Remitting Multiple Sclerosis: A Propensity Score Adjusted Comparison between Denmark and Sweden

  Spelman T; Magyari M; Piehl F; Svenningsson A; Rasmussen PV; Kant M; Sellebjerg F; Joensen H; Hillert J; Lycke J
• Article: RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS. 2021;5(1):132-141

  Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality

  von Meijenfeldt FA; Havervall S; Adelmeijer J; Lundstrom A; Rudberg A-S; Magnusson M; Mackman N; Thalin C; Lisman T
• Book chapter: DYSFAGI – VANLIGT, FARLIGT, OFTA FÖRBISETT.. 2021;p.

  Dysfagi vid intensivvård och långvarig kritisk sjukdom

  Bergström L; Sundman E
• Article: BRAIN SCIENCES. 2020;11(1):34

  Analysis of NOS Gene Polymorphisms in Relation to Cluster Headache and Predisposing Factors in Sweden

  Ran C; Michalska JM; Fourier C; Sjostrand C; Waldenlind E; Steinberg A; Belin AC
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2020;26(3_SUPPL):279-280

  Efficacy and safety in patients treated with natalizumab for at least 10 years - real-world data from a swedish national surveillance study (IMSE 1)

  Kagstrom S; Leandersson A; Forsberg L; Berglund A; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Sundstrom P; Martin C; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2020;26(3_SUPPL):252-253

  A swedish post-market surveillance study of the long-term effectiveness and safety of alemtuzumab (imse 3) for patients treated for at least 36 months

  Leandersson A; Kagstrom S; Forsberg L; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2020;26(3_SUPPL):187-188

  Relation of edss to patient-reported outcome measurements in ms: real-world data from a swedish nationwide study of fingolimod (imse 2)

  Leandersson A; Kagstrom S; Forsberg L; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2020;26(3_SUPPL):302

  Real-world data of peginterferon beta-1a from a swedish national post-marketing surveillance study (IMSE 6) - effectiveness and safety profile

  Kagstrom S; Leandersson A; Forsberg L; Berglund A; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2020;26(3_SUPPL):254-255

  A swedish post-market surveillance study: long-term effectiveness and safety of dimethyl fumarate (imse 5) for patients treated at least 36 months: on-demand eposters p0001-p0286

  Forsberg L; Kagstrom S; Leandersson A; Berglund A; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2020;26(3_SUPPL):253-254

  A swedish post-market surveillance study of the long-term effectiveness and safety of teriflunomid (IMSE 4) for patients treated at least 36 months

  Forsberg L; Kagstrom S; Leandersson A; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2020;26(3_SUPPL):254

  A swedish post-market surveillance study: long-term effectiveness and safety of cladribine tablets (IMSE 10) for patients treated at least 12 months

  Forsberg L; Kagstrom S; Leandersson A; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2020;21(12):1885-1892

  Perceived Quality of Care Transitions between Hospital and the Home in People with Stroke

  Lindblom S; Flink M; Sjostrand C; Laska A-C; von Koch L; Ytterberg C
• Conference publication: INTERNATIONAL JOURNAL OF STROKE. 2020;15(1_SUPPL):90-91

  COMPARISON OF ANTIPLATELET THERAPIES FOR PREVENTION OF STROKE RELATED TO PFO

  Kasner S; Andersen G; Iversen H; Sjostrand C; Roine R; Rhodes J; Sondergaard L
• Conference publication: EUROPEAN HEART JOURNAL. 2020;41:2365

  IL6 trans-signalling associates with atherothrombotic but not with cardioembolic stroke

  Ziegler L; Wallen H; Aspberg S; De Faire U; Gigante B
• Conference publication: INTERNATIONAL JOURNAL OF STROKE. 2020;15(1_SUPPL):48

  CLINICAL OUTCOMES OF ENDOVASCULAR THROMBECTOMY BEFORE AND AFTER THE STOCKHOLM STROKE TRIAGE PROJECT

  Keselman B; Berglund A; Ahmed N; Von Euler M; Holmin S; Laska A-C; Mathe J; Sjostrand C; Eriksson E; Mazya M
• Conference publication: INTERNATIONAL JOURNAL OF STROKE. 2020;15(1_SUPPL):411-412

  AGREEMENT BETWEEN THE SIMPLIFIED MODIFIED RANKIN SCALE QUESTIONNAIRE AND A FACE-TO FACE ASSESSMENT OF THE MODIFIED RANKIN SCALE

  Isaksson E; Laska A-C; Wester P; Nasman P; Lundstrom E
• Conference publication: INTERNATIONAL JOURNAL OF STROKE. 2020;15(1_SUPPL):338

  STAFF AND FACILITY UTILIZATION IN A COMPREHENSIVE STROKE CENTER: TESTING A REAL-TIME LOCATION SYSTEM FOR AUTOMATIC PATIENT PATHWAY CHARACTERIZATION

  Moreira T; Furnica A; Daemen E; Kaijser M; Mazya M; Sjostrand C; Van Loenen E
• Conference publication: INTERNATIONAL JOURNAL OF STROKE. 2020;15(1_SUPPL):338-339

  MOBILE-PHONE BASED STROKE COMMUNICATION TOOL DURING ACUTE STROKE CARE IN A COMPREHENSIVE STROKE CENTER: FEASIBILITY AND LOGISTICS

  Daemen E; Moreira T; Mazya M; Furnica A; Sjostrand C; Van Loenen E
• Conference publication: INTERNATIONAL JOURNAL OF STROKE. 2020;15(1_SUPPL):50

  PRO-INFLAMMATORY IL6 TRANS-SIGNALLING IS ASSOCIATED WITH ISCHEMIC STROKE BUT NOT WITH ATRIAL FIBRILLATION

  Ziegler L
• Conference publication: INTERNATIONAL JOURNAL OF STROKE. 2020;15(1_SUPPL):44

  LONG-TERM OUTCOME AFTER CAROTID ENDARTERECTOMY FOR ASYMPTOMATIC CAROTID STENOSIS- A NATIONWIDE COHORT STUDY

  Hammar K; Laska A-C; Wester P; Mani K; Jonsson M; Lundstrom A
• Article: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2020;46:102463

  NFL and CXCL13 may reveal disease activity in clinically and radiologically stable MS

  Novakova L; Axelsson M; Malmestrom C; Zetterberg H; Blennow K; Svenningsson A; Lycke J
• Article: NATURE COMMUNICATIONS. 2020;11(1):5064

  SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden

  Rudberg A-S; Havervall S; Manberg A; Jernbom Falk A; Aguilera K; Ng H; Gabrielsson L; Salomonsson A-C; Hanke L; Murrell B; McInerney G; Olofsson J; Andersson E; Hellstrom C; Bayati S; Bergstrom S; Pin E; Sjoberg R; Tegel H; Hedhammar M; Phillipson M; Nilsson P; Hober S; Thalin C
• Conference publication: CEPHALALGIA. 2020;40:36

  INVESTIGATING THE LINK BETWEEN CLUSTER HEADACHE AND GENETIC VARIANTS IN THE BIOLOGICAL CLOCK GENE PER3

  Olofsgard FMEJ; Ran C; Fourier C; Sjostrand C; Waldenlind E; Steinberg A; Belin AC
• Article: MULTIPLE SCLEROSIS JOURNAL. 2020;26(12):1532-1539

  Comparative effectiveness of dimethyl fumarate as the initial and secondary treatment for MS

  Granqvist M; Burman J; Gunnarsson M; Lycke J; Nilsson P; Olsson T; Sundstrom P; Svenningsson A; Vrethem M; Frisell T; Piehl F
• Corrigendum: JOURNAL OF STROKE & CEREBROVASCULAR DISEASES. 2020;29(8):104822

  Comparison of Antiplatelet Therapies for Prevention of Patent Foramen Ovale-Associated Stroke (vol 29, 104632, 2020)

  Kasner SE; Randall B; Andersen G; Iversen HK; Roine RO; Sjostrand C; Rhodes JF; Sondergaard L
• Article: TRANSLATIONAL STROKE RESEARCH. 2020;11(4):708-719

  Prognostic Value of Circulating Microvesicle Subpopulations in Ischemic Stroke and TIA

  Lundstrom A; Mobarrez F; Rooth E; Thalin C; von Arbin M; Henriksson P; Gigante B; Laska A-C; Wallen H
• Article: LANCET NEUROLOGY. 2020;19(8):661-669

  Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial

  Lundstrom E; Nasman P; Wester P; Martensson B; Norrving B; Wallen H; Borg J; Dennis M; Mead G; Hankey GJ; Hackett ML; Sunnerhagen KS
• Editorial: STROKE. 2020;51(8):e142-e143

  Selective Serotonin Reuptake Inhibitors for Stroke Recovery

  Legg LA; Tilney R; Hsieh C-F; Wu S; Lundstrom E; Rudberg A-S; Kutlubaev MA; Dennis M; Soleimani B; Barugh A; Hackett ML; Hankey GJ; Mead GE
• Article: FLUIDS AND BARRIERS OF THE CNS. 2020;17(1):49

  Location matters: highly divergent protein levels in samples from different CNS compartments in a clinical trial of rituximab for progressive MS

  Bergman J; Svenningsson A; Liv P; Bergenheim T; Burman J
• Article: EUROPEAN STROKE JOURNAL. 2020;5(2):193-203

  SiPP (Stroke in Pregnancy and Postpartum): A prospective, observational, international, multicentre study on pathophysiological mechanisms, clinical profile, management and outcome of cerebrovascular diseases in pregnant and postpartum women

  Lorenzano S; Kremer C; Pavlovic A; Jovanovic DR; Sandset EC; Christensen H; Bushnell C; Arsovska A; Sprigg N; Roffe C; Ijas P; Gdovinova Z; Alexandrov A; Zedde M; Tassi R; Acciaresi M; Lantz M; Sunnerhagen K; Zarkov M; Rantanen K; Perren F; Iversen HK; Kruuse C; Slowik A; Palazzo P; Korv J; Fromm A; Lovrencic-Huzjan A; Korompoki E; Fonseca AC; Gall SL; Brunner F; Caso V; Sacco S; Toni D; Tomek A
• Article: INTERNATIONAL JOURNAL OF STROKE. 2020;15(4):365-376

  Fluoxetine for stroke recovery: Meta-analysis of randomized controlled trials

  Mead GE; Legg L; Tilney R; Hsieh CF; Wu S; Lundstrom E; Rudberg AS; Kutlubaev M; Dennis MS; Soleimani B; Barugh A; Hackett ML; Hankey GJ
• Article: JAMA NEUROLOGY. 2020;77(6):691-699

  Implementation of a Prehospital Stroke Triage System Using Symptom Severity and Teleconsultation in the Stockholm Stroke Triage Study

  Mazya MV; Berglund A; Ahmed N; von Euler M; Holmin S; Laska A-C; Mathe JM; Sjostrand C; Eriksson EE
• Article: NEUROLOGY. 2020;94(21):e2213-e2221

  Sickness absence and disability pension days in patients with cluster headache and matched references

  Sjostrand C; Alexanderson K; Josefsson P; Steinberg A
• Article: LAKARTIDNINGEN. 2020;117:FX4L

  [Orthostatic tremor - a disregarded diagnosis].

  Af Edholm Arvidsson K; Paucar M; Svenningsson P
• Corrigendum: TRIALS. 2020;21(1):388

  Update on the EFFECTS study of fluoxetine for stroke recovery: a randomised controlled trial in Sweden (vol 21, 233, 2020)

  Lundstrom E; Isaksson E; Nasman P; Wester P; Martensson B; Norrving B; Wallen H; Borg J; Dennis M; Mead G; Hankey GJ; Hackett ML; Sunnerhagen KS
• Article: INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY. 2020;22(3):302-312

  Communicating simply, but not too simply: Reporting of participants and speech and language interventions for aphasia after stroke

  Brady MC; Ali M; VandenBerg K; Williams LJ; Williams LR; Abo M; Becker F; Bowen A; Brandenburg C; Breitenstein C; Bruehl S; Copland DA; Cranfill TB; di Pietro-Bachmann M; Enderby P; Fillingham J; Galli FL; Gandolfi M; Glize B; Godecke E; Hawkins N; Hilari K; Hinckley J; Horton S; Howard D; Jaecks P; Jefferies E; Jesus LM; Kambanaros M; Kang EK; Khedr EM; Kong AP-H; Kukkonen T; Laganaro M; Lambon-Ralph MA; Laska AC; Leemann B; Leff AP; Lima RR; Lorenz A; MacWhinney B; Marshall RS; Mattioli F; Mavis I; Meinzer M; Nilipour R; Noe E; Paik N-J; Palmer R; Papathanasiou I; Patricio BF; Martins IP; Price C; Jakovac TP; Rochon E; Rose ML; Rosso C; Rubi-Fessen I; Ruiter MB; Snell C; Stahl B; Szaflarski JP; Thomas SA; van de Sandt-Koenderman M; van der Meulen I; Visch-Brink E; Worrall L; Wright HH
• Article: EUROPEAN JOURNAL OF NEUROLOGY. 2020;27(5):871-877

  Prevention of post-dural puncture headache: a randomized controlled trial

  Salzer J; Granasen G; Sundstrom P; Vagberg M; Svenningsson A
• Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2020;27:14-15

  Prevention of post-dural puncture headache - a randomized controlled trial

  Salzer J; Granasen G; Sundstrom P; Vagberg M; Svenningsson A
• Article: ANNALS OF NEUROLOGY. 2020;87(5):688-699

  Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients

  Alping P; Askling J; Burman J; Fink K; Fogdell-Hahn A; Gunnarsson M; Hillert J; Langer-Gould A; Lycke J; Nilsson P; Salzer J; Svenningsson A; Vrethem M; Olsson T; Piehl F; Frisell T
• Article: LAKARTIDNINGEN. 2020;117:F3S3

  [ACE2 and coronavirus - a question of balance and dynamics?].

  Lundström A; Sandén P
• Review: THROMBOSIS AND HAEMOSTASIS. 2020;120(4):538-564

  Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis

  d'Alessandro E; Becker C; Bergmeier W; Bode C; Bourne JH; Brown H; Buller HR; ten Cate-Hoek AJ; ten Cate V; van Cauteren YJM; Cheung YFH; Cleuren A; Coenen D; Crijns HJGM; de Simone I; Dolleman SC; Klein CE; Fernandez DI; Granneman L; van t Hof A; Henke P; Henskens YMC; Huang J; Jennings LK; Jooss N; Karel M; van den Kerkhof D; Klok FA; Kremers B; Laemmle B; Leader A; Lundstrom A; Mackman N; Mannucci PM; Maqsood Z; van der Meijden PEJ; van Moorsel M; Moran LA; Morser J; van Mourik M; Navarro S; Neagoe RAI; Olie RH; van Paridon P; Posma J; Provenzale I; Reitsma PH; Scaf B; Schurgers L; Seelig J; Siegbahn A; Siegerink B; Soehnlein O; Soriano EM; Sowa MA; Spronk HMH; Storey RF; Tantiwong C; Veninga A; Wang X; Watson SP; Weitz J; Zeerleder SS; ten Cate H; Lina B; Christoph B; Marc H; Peter K; GregoryLip KR; Steffen M; Philipp VH; Christian W; Johann W
• Article: LANCET NEUROLOGY. 2020;19(4):307-316

  Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study

  He A; Merkel B; Brown JWL; Ryerson LZ; Kister I; Malpas CB; Sharmin S; Horakova D; Havrdova EK; Spelman T; Izquierdo G; Eichau S; Trojano M; Lugaresi A; Hupperts R; Sola P; Ferraro D; Lycke J; Grand'Maison F; Prat A; Girard M; Duquette P; Larochelle C; Svenningsson A; Petersen T; Grammond P; Granella F; Van Pesch V; Bergamaschi R; McGuigan C; Coles A; Hillert J; Piehl F; Butzkueven H; Kalincik T
• Article: JOURNAL OF STROKE & CEREBROVASCULAR DISEASES. 2020;29(4):104632

  Comparison of Antiplatelet Therapies for Prevention of Patent Foramen Ovale-Associated Stroke

  Kasner SE; Randall B; Andersen G; Iversen HK; Roine R; Sjostrand C; Rhodes JF; Sondergaard L
• Article: LANCET. 2020;395(10227):878-887

  Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial

  Hill MD; Goyal M; Menon BK; Nogueira RG; McTaggart RA; Demchuk AM; Poppe AY; Buck BH; Field TS; Dowlatshahi D; van Adel BA; Swartz RH; Shah RA; Sauvageau E; Zerna C; Ospel JM; Joshi M; Almekhlafi MA; Ryckborst KJ; Lowerison MW; Heard K; Garman D; Haussen D; Cutting SM; Coutts SB; Roy D; Rempel JL; Rohr ACR; Lancu D; Sahlas DJ; Yu AYX; Devlin TG; Hanel RA; Puetz V; Silver FL; Campbell BCV; Chapot R; Teitelbaum J; Mandzia JL; Kleinig TJ; Turkel-Parrella D; Heck D; Kelly ME; Bharatha A; Bang OY; Jadhav A; Gupta R; Frei DF; Tarpley JW; McDougall CG; Holman S; Rha J-H; Puri AS; Camden M-C; Thomalla G; Choe H; Phillips SJ; Schindler JL; Thornton J; Nagel S; Heo JH; Sohn S-I; Psychogios M-N; Budzik RF; Starkman S; Martin CO; Burns PA; Murphy S; Lopez GA; English J; Tymianski M
• Study protocol: TRIALS. 2020;21(1):233

  Update on the EFFECTS study of fluoxetine for stroke recovery: a randomised controlled trial in Sweden

  Lundstrom E; Isaksson E; Nasman P; Wester P; Martensson B; Norrving B; Wallen H; Borg J; Dennis M; Mead G; Hankey GJ; Hackett ML; Sunnerhagen KS
• Doctoral thesis: 2020

  Interleukin 6 trans-signalling : cardiovascular risk marker or therapeutical target?

  Ziegler L
• Article: METABOLOMICS. 2020;16(2):26

  Targeted metabolomics of CSF in healthy individuals and patients with secondary progressive multiple sclerosis using high-resolution mass spectrometry

  Carlsson H; Abujrais S; Herman S; Khoonsari PE; Akerfeldt T; Svenningsson A; Burman J; Kultima K
• Review: APHASIOLOGY. 2020;34(2):137-157

  RELEASE: a protocol for a systematic review based, individual participant data, meta- and network meta-analysis, of complex speech-language therapy interventions for stroke-related aphasia

  Brady MC; Ali M; VandenBerg K; Williams LJ; Williams LR; Abo M; Becker F; Bowen A; Brandenburg C; Breitenstein C; Bruehl S; Copland DA; Cranfill TB; di Pietro-Bachmann M; Enderby P; Fillingham J; Galli FL; Gandolfi M; Glize B; Godecke E; Hawkins N; Hilari K; Hinckley J; Horton S; Howard D; Jaecks P; Jefferies E; Jesus LMT; Kambanaros M; Kang EK; Khedr EM; Kong AP-H; Kukkonen T; Laganaro M; Ralph MAL; Laska AC; Leemann B; Leff AP; Lima RR; Lorenz A; MacWhinney B; Marshall RS; Mattioli F; Mavis I; Meinzer M; Nilipour R; Noe E; Paik N-J; Palmer R; Papathanasiou I; Patricio BF; Martins IP; Price C; Jakovac TP; Rochon E; Rose ML; Rosso C; Rubi-Fessen I; Ruiter MB; Snell C; Stahl B; Szaflarski JP; Thomas SA; van de Sandt-Koenderman M; van der Meulen I; Visch-Brink E; Worrall L; Wright HH
• Journal article: STROKE. 2020;51(Suppl_1)

  Abstract WMP110: Presence, Volume, and Location of New Ischemic Injury on MRI in Stroke Patients Who Undergo PFO Closure Compared to Patients Treated Medically: An Analysis of the REDUCE Trial

  Messe SR; Erus G; Bilello M; Davatzikos C; Andersen G; Iversen H; Roine RO; Sjostrand C; Herrmann HC; Rhodes JF; Sondergaard L; Kasner SE
• Article: JAMA NEUROLOGY. 2020;77(2):184-191

  Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

  Luna G; Alping P; Burman J; Fink K; Fogdell-Hahn A; Gunnarsson M; Hillert J; Langer-Gould A; Lycke J; Nilsson P; Salzer J; Svenningsson A; Vrethem M; Olsson T; Piehl F; Frisell T
• Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2020;27(2):122-129

  The predictive role of interleukin 6 trans-signalling in middle-aged men and women at low-intermediate risk of cardiovascular events

  Ziegler L; Frumento P; Wallen H; de Faire U; Gigante B
• Article: EUROPEAN NEUROLOGY. 2020;83(5):493-499

  Validation of the Simplified Modified Rankin Scale Questionnaire

  Isaksson E; Wester P; Laska AC; Nasman P; Lundstrom E
• Other: NEUROLOGY: CLINICAL PRACTICE. 2019;9(6):519-521

  Serum sickness following rituximab therapy in multiple sclerosis

  Holmoy T; Fogdell-Hahn A; Svenningsson A
• Article: EUROPEAN STROKE JOURNAL. 2019;4(4):307-317

  Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11-13 November 2018

  Ahmed N; Audebert H; Turc G; Cordonnier C; Christensen H; Sacco S; Sandset EC; Ntaios G; Charidimou A; Toni D; Pristipino C; Koehrmann M; Kuramatsu JB; Thomalla G; Mikulik R; Ford GA; Marti-Fabregas J; Fischer U; Thoren M; Lundstrom E; Rinkel GJE; van der Worp HB; Matusevicius M; Tsivgoulis G; Milionis H; Rubiera M; Hart R; Moreira T; Lantz M; Sjostrand C; Andersen G; Schellinger P; Kostulas K; Sunnerhagen KS; Keselman B; Korompoki E; Purrucker J; Khatri P; Whiteley W; Berge E; Mazya M; Dippel DWJ; Mustanoja S; Rasmussen M; Soderqvist AK; Escudero-Martinez I; Steiner T
• Letter: PAIN. 2019;160(12):2898-2899

  Anti-inflammatory drugs with more penetration into the central nervous system may contribute to the treatment of trigeminal neuralgia Reply

  Ericson H; Abu Hamdeh S; Freyhult E; Stiger F; Backryd E; Svenningsson A; Gordh T; Kultima K
• Review: COCHRANE DATABASE OF SYSTEMATIC REVIEWS. 2019;2019(11)

  Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery

  Legg LA; Tilney R; Hsieh C-F; Wu S; Lundstrom E; Rudberg A-S; Kutlubaev MA; Dennis M; Soleimani B; Barugh A; Hackett ML; Hankey GJ; Mead GE
• Article: PAIN. 2019;160(11):2603-2611

  Cerebrospinal fluid biomarkers of inflammation in trigeminal neuralgia patients operated with microvascular decompression

  Ericson H; Abu Hamdeh S; Freyhult E; Stiger F; Backryd E; Svenningsson A; Gordh T; Kultima K
• Article: TRIALS. 2019;20(1):618

  Identifying important barriers to recruitment of patients in randomised clinical studies using a questionnaire for study personnel

  Isaksson E; Wester P; Laska AC; Nasman P; Lundstrom E
• Journal article: EUROPEAN HEART JOURNAL. 2019;40(Supplement_1):ehz748.0281

  P1519IL6 trans-signalling affects risk of cardiovascular events pre-eminently in men

  Ziegler L; Frumento P; Wallen H; De Faire U; Gigante B
• Conference publication: EUROPEAN HEART JOURNAL. 2019;40:824

  IL6 trans-signalling affects risk of cardiovascular events pre-eminently in men

  Ziegler L; Frumento P; Wallen H; De Faire U; Gigante B
• Conference publication: CEPHALALGIA. 2019;39:18

  Circadian rhythm gene expression in cluster headache

  Ran C; Liesecke F; Fourier C; Steinberg A; Sjostrand C; Waldenlind E; Belin AC
• Conference publication: CEPHALALGIA. 2019;39:17-18

  Gender differences in cluster headache in Sweden

  Fourier C; Ran C; Steinberg A; Sjostrand C; Waldenlind E; Belin AC
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:282

  NFL and CXCL13 reveal disease activity in clinically and radiologically stable MS

  Nyren LN; Axelsson M; Malmestrom C; Svenningsson A; Zetterberg H; Blennow K; Lycke J
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:327-328

  A swedish post-market surveillance study of the long-term effectiveness and safety of alemtuzumab (IMSE 3) for patients treated at least 24 months

  Falt A; Kagstrom S; Forsberg L; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:20

  Risk of hypogammaglobulinemia in long-term treatment with rituximab in multiple sclerosis

  Hallberg S; Boremalm M; Evertsson B; Lillvall E; Johansson F; Lycke J; Piehl F; Salzer J; Svenningsson A
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:763-764

  Improved clinical outcomes in patients treated with natalizumab for at least 8 years - real-world data from a Swedish national post-marketing surveillance study (IMSE 1)

  Kagstrom S; Falt A; Forsberg L; Berglund A; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Sundstrom P; Martin C; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:316

  A Swedish Nationwide study of the long-term effectiveness and safety of teriflunomid based on data from the Swedish "Immunomodulation and Multiple Sclerosis Epidemiology" Study (IMSE 4)

  Forsberg L; Kagstrom S; Falt A; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:316-317

  Clinical effectiveness of dimethyl fumarate with focus on patients treated at least 36 months - a Swedish nationwide study of the long-term effectiveness and safety of dimethyl fumarate (IMSE5)

  Forsberg L; Kagstrom S; Falt A; Berglund A; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:432-433

  Poor correlation between protein levels in different CNS compartments in patients with progressive MS

  Bergman J; Svenningsson A; Liv P; Burman J
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:536-537

  A Swedish real word study of the long-term effectiveness and safety of fingolimod (IMSE 2) with focus on patients treated at least 48 months

  Falt A; Kagstrom S; Forsberg L; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Review: JAMA NEUROLOGY. 2019;76(9):1035-1048

  Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

  Bridel C; van Wieringen WN; Zetterberg H; Tijms BM; Teunissen CE; Alvarez-Cermeno JC; Andreasson U; Axelsson M; Backstrom DC; Bartos A; Bjerke M; Blennow K; Boxer A; Brundin L; Burman J; Christensen T; Fialova L; Forsgren L; Frederiksen JL; Gisslen M; Gray E; Gunnarsson M; Hall S; Hansson O; Herbert MK; Jakobsson J; Jessen-Krut J; Janelidze S; Johannsson G; Jonsson M; Kappos L; Khademi M; Khalil M; Kuhle J; Landen M; Leinonen V; Logroscino G; Lu C-H; Lycke J; Magdalinou NK; Malaspina A; Mattsson N; Meeter LH; Mehta SR; Modvig S; Olsson T; Paterson RW; Perez-Santiago J; Piehl F; Pijnenburg YAL; Pyykko OT; Ragnarsson O; Rojas JC; Christensen JR; Sandberg L; Scherling CS; Schott JM; Sellebjerg FT; Simone IL; Skillback T; Stilund M; Sundstrom P; Svenningsson A; Tortelli R; Tortorella C; Trentini A; Troiano M; Turner MR; van Swieten JC; Vagberg M; Verbeek MM; Villar LM; Visser PJ; Wallin A; Weiss A; Wikkelso C; Wild EJ
• Article: JOURNAL OF NEUROLOGY. 2019;266(9):2208-2215

  Lower risk of multiple sclerosis in patients with chronic hepatitis C: a nationwide population-based registry study

  Soderholm J; Yilmaz A; Svenningsson A; Busch K; Wejstal R; Brolund A; Kovamees J; Sallberg M; Lagging M; Gisslen M
• Other: LAKARTIDNINGEN. 2019;116:FL4F

  [Diagnostic challenge in a man with intractable hiccups and vomiting: a case of neuromyelitis optica spectrum disorder (NMOSD)].

  Kaloudi D; Svenningsson A; von Heijne A
• Article: EUROPEAN JOURNAL OF NEUROLOGY. 2019;26(8):1060-1067

  Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis

  Boremalm M; Juto A; Axelsson M; Novakova L; Frisell T; Svenningsson A; Lycke J; Piehl F; Selzer J
• Article: BRAIN SCIENCES. 2019;9(8):E184-184

  Anoctamin 3: A Possible Link between Cluster Headache and Ca²⁺ Signaling

  Ran C; Fourier C; Arafa D; Liesecke F; Sjostrand C; Waldenlind E; Steinberg A; Belin AC
• Article: NEUROLOGY. 2019;93(4):e404-e413

  Cluster headache Prevalence, sickness absence, and disability pension in working

  Steinberg A; Josefsson P; Alexanderson K; Sjostrand C
• Article: JOURNAL OF NEUROIMMUNOLOGY. 2019;332:31-36

  Measurement of sCD27 in the cerebrospinal fluid identifies patients with neuroinflammatory disease

  Feresiadou A; Nilsson K; Ingelsson M; Press R; Kmezic I; Nygren I; Svenningsson A; Niemela V; Gordh T; Cunningham J; Kultima K; Larsson A; Burman J
• Article: HEALTH TECHNOLOGY ASSESSMENT. 2019;23(35):1-48

  Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT

  Sprigg N; Flaherty K; Appleton JP; Salman RA-S; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Dulev L; Jose Egea-Guerrero J; England TJ; Karlinsk M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Hanabalan J; Werring D; Whynes D; Woodriouse L; Bath PM
• Article: ACTA NEUROLOGICA SCANDINAVICA. 2019;139(5):462-468

  Comparison of plasma and cerebrospinal fluid neurofilament light in a multiple sclerosis trial

  de Flon P; Laurell K; Sundstrom P; Blennow K; Soderstrom L; Zetterberg H; Gunnarsson M; Svenningsson A
• Article: STROKE AND VASCULAR NEUROLOGY. 2019;4(1):28-35

  It is safe to use transdermal glyceryl trinitrate to lower blood pressure in patients with acute ischaemic stroke with carotid stenosis

  Appleton JP; Woodhouse LJ; Belcher A; Bereczki D; Berge E; Caso V; Chang HM; Christensen HK; Collins R; Gommans J; Laska AC; Ntaios G; Ozturk S; Sare GM; Szatmari S; Wang Y; Wardlaw JM; Sprigg N; Bath PM
• Article: EPIDEMIOLOGY. 2019;30(2):230-233

  Validation of the Swedish Multiple Sclerosis Register Further Improving a Resource for Pharmacoepidemiologic Evaluations

  Alping P; Piehl F; Langer-Gould A; Frisell T; Burman J; Fink K; Fogdell-Hahn A; Gunnarsson M; Hillert J; Kockum I; Lycke J; Nilsson P; Olsson T; Salzer J; Svenningsson A; Virtanen S; Vrethem M
• Article: HEADACHE. 2019;59(3):410-417

  Analysis of HCRTR2 Gene Variants and Cluster Headache in Sweden

  Fourier C; Ran C; Steinberg A; Sjostrand C; Waldenlind E; Belin AC
• Editorial: NEUROLOGY. 2019;92(7):313-314

  Serum neurofilament light and prediction of multiple sclerosis in clinically isolated syndrome

  Zetterberg H; Svenningsson A
• Editorial: NEUROLOGY. 2019;92(6):e622-e625

  Clinical Reasoning: Leg weakness and stiffness at the emergency room

  af Edholm K; Lidman C; Andersson S; Solders G; Paucar M
• Article: BMC GERIATRICS. 2019;19(1):31

  Temporal trends in incidence, recurrence and prevalence of stroke in an era of ageing populations,a longitudinal study of the total Swedish population

  Modig K; Talback M; Ziegler L; Ahlbom A
• Article: INTERNATIONAL JOURNAL OF STROKE. 2019;14(2):180-185

  A core outcome set for aphasia treatment research: The ROMA consensus statement

  Wallace SJ; Worrall L; Rose T; Le Dorze G; Breitenstein C; Hilari K; Babbitt E; Bose A; Brady M; Cherney LR; Copland D; Cruice M; Enderby P; Hersh D; Howe T; Kelly H; Kiran S; Laska A-C; Marshall J; Nicholas M; Patterson J; Pearl G; Rochon E; Rose M; Sage K; Small S; Webster J
• Letter: HEADACHE. 2019;59(2):266-267

  Moderate to High Levels of Neurofilament Light in Two Patients with HaNDL

  Sveinsson O; Saflund M; Sjostrand C
• Article: MULTIPLE SCLEROSIS JOURNAL - EXPERIMENTAL, TRANSLATIONAL AND CLINICAL. 2019;5(1):2055217319826598

  Inflammatory activity and vitamin D levels in an MS population treated with rituximab

  Linden J; Granasen G; Salzer J; Svenningsson A; Sundstrom P
• Conference publication: JOURNAL OF VASCULAR RESEARCH. 2019;56:87

  Characterization of a Novel CADASIL-Like Mutation in the NOTCH3 Receptor

  Arnardottir S; Del Gaudio F; Lombrana AA; Oliveira DV; Karlstrom H; Lendahl U; Sjostrand C
• Journal article: CEPHALALGIA REPORTS. 2019;2:2515816319879886

  Involvement of CGRP receptor RAMP1 in cluster headache: A Swedish case-control study

  Michalska JM; Ran C; Fourier C; Steinberg A; Sjöstrand C; Waldenlind E; Belin AC
• Article: CARDIOVASCULAR RESEARCH. 2019;115(1):213-221

  Interleukin 6 trans-signalling and risk of future cardiovascular events

  Ziegler L; Gajulapuri A; Frumento P; Bonomi A; Wallen H; de Faire U; Rose-John S; Gigante B
• Conference publication: INTERNATIONAL JOURNAL OF STROKE. 2018;13:59

  Multi-professional teamwork in stroke units - time to understand the impact of the built environment on the work of staff

  Anaker A; von Koch L; Eriksson G; Sjostrand C; Elf M
• Letter: JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2018;72(20):2542-2544

  Characterization of Recurrent Strokes With and Without Patent Foramen Ovale Closure.

  Kasner SE; Kase CS; Turan TN; Rowley HA; Andersen G; Iversen HK; Roine RO; Messé SR; Volpi J; Søndergaard L; Rhodes JF; Sjöstrand C; REDUCE Study Investigators
• Article: NEUROLOGY. 2018;91(20):e1893-e1901

  Intrathecal treatment trial of rituximab in progressive MS An open-label phase 1b study

  Bergman J; Burman J; Gilthorpe JD; Zetterberg H; Jiltsova E; Bergenheim T; Svenningsson A
• Article: JOURNAL OF HEADACHE AND PAIN. 2018;19(1):100

  Implications for the migraine SNP rs1835740 in a Swedish cluster headache population

  Ran C; Fourier C; Zinnegger M; Steinberg A; Sjoestrand C; Waldenlind E; Belin AC
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2018;24:701-702

  A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of dimethyl fumarate (IMSE 5)

  Demirbuker SS; Kagstrom S; Falt A; Berglund A; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Sundstrom P; Martin C; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2018;24:927-928

  Real-world longitudinal data of peginterferon beta-1a from a Swedish national post-marketing surveillance study (IMSE 6) - efficacy and safety profile

  Kagstrom S; Falt A; Demirbuker SS; Berglund A; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2018;24:706-707

  A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of alemtuzumab (IMSE 3)

  Falt A; Kagstrom S; Demirbuker SS; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2018;24:922-923

  A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of teriflunomid (IMSE 4)

  Demirbuker SS; Kagstrom S; Falt A; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Sundstrom P; Martin C; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2018;24:699-700

  A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of natalizumab (IMSE 1)

  Kagstrom S; Falt A; Demirbuker SS; Berglund A; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2018;24:696-697

  A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of fingolimod (IMSE 2)

  Falt A; Kagstrom S; Demirbuker SS; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2018;27(2_SUPPL):616-617

  A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of alemtuzumab (IMSE 3)

  Ekstrom E; Rosengren V; Kagstrom S; Forsberg L; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2018;27(2_SUPPL):626-627

  Real-world longitudinal data of peginterferon beta-1a from the Swedish national post-marketing surveillance study (IMSE 6) - effectiveness and safety profile

  Ekstrom E; Rosengren V; Kagstrom S; Forsberg L; Berglund A; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Martin C; Sundstrom P; Gunnarsson M; Piehl F; Olsson T
• Conference publication: JOURNAL OF HEADACHE AND PAIN. 2018;19

  Sickness absence and disability pension in cluster headache patients and in matched references: a population-based study

  Steinberg A; Josefsson P; Alexandersson K; Sjostrand C
• Article: INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY. 2018;20(5):494-501

  Community listeners' perceptions of voice function post-radiotherapy for laryngeal cancer

  Bergstrom L; Ward EC; Finizia C
• Conference publication: CEPHALALGIA. 2018;38:24

  INVOLVEMENT OF CGRP RECEPTOR RAMP1 IN CLUSTER HEADACHE - A SWEDISH CASE-CONTROL STUDY

  Michalska J; Fourier C; Steinberg A; Sjostrand C; Waldenlind E; Ran C; Belin AC
• Conference publication: CEPHALALGIA. 2018;38:23

  POTENTIAL CANDIDATE GENES FOR CLUSTER HEADACHE INVOLVED IN CA2+SIGNALING AND T-CELL DIFFERENTIATION

  Ran C; Fourier C; Steinberg A; Sjostrand C; Waldenlind E; Belin AC
• Article: SCIENTIFIC REPORTS. 2018;8(1):12641

  Circulating H3Cit is elevated in a human model of endotoxemia and can be detected bound to microvesicles

  Goranson SP; Thalin C; Lundstrom A; Hallstrom L; Lasselin J; Wallen H; Soop A; Mobarrez F
• Journal article: EUROPEAN HEART JOURNAL. 2018;39(suppl_1):ehy565.p2625

  P2625The soluble IL6 receptor and ischemic cerebrovascular disease

  Ziegler L; Lundqvist J; Perisic L; Gajulapuri A; Dreij K; Frumento P; Paulsson-Berne G; Wallen H; De Faire U; Hedin U; Gigante B
• Conference publication: EUROPEAN HEART JOURNAL. 2018;39:1340

  Atrial fibrillation after closure of persistent foramen ovale in the REDUCE clinical trial

  Nielsen-Kudsk JE; Andersen A; Andersen G; Sjostrand C; Rhodes JF; Kasner SE; Sondergaard L
• Journal article: EUROPEAN HEART JOURNAL. 2018;39(suppl_1):ehy566.p6382

  P6382Atrial fibrillation after closure of persistent foramen ovale in the REDUCE clinical trial

  Nielsen-Kudsk JE; Andersen A; Andersen G; Sjostrand C; Rhodes JF; Kasner SE; Sondergaard L; investigators R
• Conference publication: EUROPEAN HEART JOURNAL. 2018;39:524-525

  The soluble IL6 receptor and ischemic cerebrovascular disease

  Ziegler L; Lundqvist J; Perisic L; Gajulapuri A; Dreij K; Frumento P; Paulsson-Berne G; Wallen H; De Faire U; Hedin U; Gigante B
• Journal article: AFRICAN JOURNAL OF MARINE SCIENCE. 2018;40(3):323-329

  Environmental responses of jellyfish polyps as drivers of medusa populations off the coast of Namibia

  Ziegler L; Gibbons MJ
• Journal article: REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE. 2018;66:s366

  Incidence, recurrence and prevalence of stroke in an ageing population

  Modig K; Ahlbom A; Talback M; Ziegler L
• Article: INTERNATIONAL JOURNAL OF QUALITATIVE STUDIES ON HEALTH AND WELL-BEING. 2018;13(sup1):1522194

  Experiences of living with persisting post-stroke dysphagia and of dysphagia management - a qualitative study

  Hellden J; Bergstrom L; Karlsson S
• Article: EUROPEAN STROKE JOURNAL. 2018;3(2):157-164

  Long-term health-related quality of life, survival and costs by different levels of functional outcome six months after stroke

  Rudberg A-S; Berge E; Gustavsson A; Nasman P; Lundstrom E
• Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2018;25:153

  The role of admission cholesterol levels on short- and long-term survival after ischaemic stroke.

  Markaki I; Klironomos S; Kostulas K; Sjostrand C
• Article: CEPHALALGIA. 2018;38(7):1286-1295

  Cluster headache - clinical pattern and a new severity scale in a Swedish cohort

  Steinberg A; Fourier C; Ran C; Waldenlind E; Sjostrand C; Belin AC
• Article: LANCET. 2018;391(10135):2107-2115

  Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial

  Sprigg N; Flaherty K; Appleton JP; Salman RA-S; Bereczki D; Beridze M; Christensen H; Ciccone A; Collins R; Czlonkowska A; Dineen RA; Duley L; Jose Egea-Guerrero J; England TJ; Krishnan K; Laska AC; Law ZK; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Seiffge D; Scutt P; Thanabalan J; Werring D; Whynes D; Bath PM
• Doctoral thesis: 2018

  Platelet function and thrombin generation in ischemic stroke : clinical correlates and prognostic importance

  Lundström A
• Article: JOURNAL OF ADVANCED NURSING. 2018;74(8):1919-1931

  The physical environment and patients' activities and care: A comparative case study at three newly built stroke units

  Anaker A; von Koch L; Sjostrand C; Heylighen A; Elf M
• Article: TRANSLATIONAL STROKE RESEARCH. 2018;9(2):120-129

  Route of Feeding as a Proxy for Dysphagia After Stroke and the Effect of Transdermal Glyceryl Trinitrate: Data from the Efficacy of Nitric Oxide in Stroke Randomised Controlled Trial

  Woodhouse LJ; Scutt P; Hamdy S; Smithard DG; Cohen DL; Roffe C; Bereczki D; Berge E; Bladin CF; Caso V; Christensen HK; Collins R; Czlonkowska A; de Silva A; Etribi A; Laska A-C; Ntaios G; Ozturk S; Phillips SJ; Prasad K; Szatmari S; Sprigg N; Bath PM
• Article: JAMA NEUROLOGY. 2018;75(3):320-327

  Comparative Effectiveness of Rituximab and Other Initial Treatment Choices for Multiple Sclerosis

  Granqvist M; Boremalm M; Poorghobad A; Svenningsson A; Salzer J; Frisell T; Piehl F
• Article: CEPHALALGIA. 2018;38(3):496-502

  A genetic CLOCK variant associated with cluster headache causing increased mRNA levels

  Fourier C; Ran C; Zinnegger M; Johansson A-S; Sjostrand C; Waldenlind E; Steinberg A; Belin AC
• Review: LAKARTIDNINGEN. 2018;115:EWPH

  [The syndrome of transient headache and neurologic deficits with cerebrospinal fluid lymphocytosis (HaNDL)].

  Säflund M; Sjöstrand C; Sveinsson O
• Article: PLOS ONE. 2018;13(2):e0192516

  Immunological profile in cerebrospinal fluid of patients with multiple sclerosis after treatment switch to rituximab and compared with healthy controls

  de Flon P; Soderstrom L; Laurell K; Dring A; Sundstrom P; Gunnarsson M; Svenningsson A
• Article: ACTA NEUROLOGICA SCANDINAVICA. 2018;137(2):252-255

  Point-of-care versus central laboratory testing of INR in acute stroke

  Zenlander R; von Euler M; Antovic J; Berglund A
• Journal article: STROKE. 2018;49(Suppl_1)

  Abstract 102: Consistency of Efficacy of PFO Closure in the Gore Reduce Trial

  Kasner SE; Sondergaard L; Rhodes JF; Anderson G; Iversen HK; Nielsen-Kudsk JE; Settergren M; Sjostrand C; Roine RO; Hildick-Smith D; Spence JD; Thomassen L
• Article: PLOS ONE. 2018;13(1):e0191231

  Citrullinated histone H3 as a novel prognostic blood marker in patients with advanced cancer

  Thalin C; Lundstrom S; Seignez C; Daleskog M; Lundstrom A; Henriksson P; Helleday T; Phillipson M; Wallen H; Demers M
• Study protocol: TRIALS. 2018;19(1):14

  Enhancing Recruitment Using Teleconference and Commitment Contract (ERUTECC): study protocol for a randomised, stepped-wedge cluster trial within the EFFECTS trial

  Lundstrom E; Isaksson E; Wester P; Laska A-C; Nasman P
• Article: TRIALS. 2017;18(1):627

  The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: statistical and health economic analysis plan for the trials and for the individual patient data meta-analysis

  Graham C; Lewis S; Forbes J; Mead G; Hackett ML; Hankey GJ; Gommans J; Huy TN; Lundstrom E; Isaksson E; Nasman P; Rudberg A-S; Dennis M
• Editorial: NEUROLOGY. 2017;89(23):2308-2309

  Cortico-juxtacortical and periventricular lesions and MS diagnostic criteria

  Svenningsson A; Ciccarelli O
• Article: TRANSLATIONAL STROKE RESEARCH. 2017;8(6):541-548

  Infections Up to 76 Days After Stroke Increase Disability and Death

  Learoyd AE; Woodhouse L; Shaw L; Sprigg N; Bereczki D; Berge E; Caso V; Christensen H; Collins R; Czlonkowska A; El Etribi A; Farr TD; Gommans J; Laska A-C; Ntaios G; Ozturk S; Pocock SJ; Prasad K; Wardlaw JM; Fone KC; Bath PM; Trueman RC
• Article: NEUROLOGY. 2017;89(22):2230-2237

  Monitoring disease activity in multiple sclerosis using serum neurofilament light protein

  Novakova L; Zetterberg H; Sundstrom P; Axelsson M; Khademi M; Gunnarsson M; Malmestrom C; Svenningsson A; Olsson T; Piehl F; Blennow K; Lycke J
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2017;23:714

  Baseline characteristics from the COMBAT-MS study: Initial analyses suggest main driver for therapy choice is geographic location

  Alping P; Burman J; Fink K; Gunnarsson M; Lycke J; Nilsson P; Salzer J; Vrethem M; Langer-Gould A; Svenningsson A; Frisell T; Piehl F
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2017;23:1004

  Vitamin D levels in a multiple sclerosis population treated with rituximab

  Linden J; Salzer J; Svenningsson A; Sundstrom P
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2017;23:841

  NFL and CXCL13 reveal disease activity in clinically and neuro-radiologically stable MS

  Novakova L; Axelsson M; Malmestrom C; Svenningsson A; Zetterberg H; Blennow K; Lycke J
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2017;23:373-374

  Comparative effectiveness of first line treatment strategies for multiple sclerosis

  Granqvist M; Boremalm M; Poorghobad A; Svenningsson A; Salzer J; Frisell T; Piehl F
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2017;23:374-375

  A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of fingolimod (IMSE 2)

  Leandersson A; Kagstrom S; Forsberg L; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Walentin F; Martin C; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2017;23:17-18

  Monitoring treatment response in MS by serum NFL reflects treatment efficacy

  Novakova L; Zetterberg H; Axelsson M; Malmestrom C; Svenningsson A; Blennow K; Lycke J
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2017;23:888-889

  A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of alemtuzumab (IMSE 3)

  Leandersson A; Kagstrom S; Forsberg L; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Walentin F; Martin C; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2017;23:626-627

  Real-world longitudinal data of peginterferon beta-1a from a Swedish national post-marketing surveillance study (IMSE 6) - efficacy and safety profile

  Kagstrom S; Leandersson A; Forsberg L; Berglund A; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Walentin F; Martin C; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2017;23:365-366

  A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of natalizumab (IMSE 1)

  Kagstrom S; Leandersson A; Forsberg L; Berglund A; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Walentin F; Martin C; Piehl F; Olsson T
• Article: BRAIN. 2017;140(10):2653-2662

  Migraine and risk of stroke: a national population-based twin study

  Lantz M; Sieurin J; Sjolander A; Waldenlind E; Sjostrand C; Wirdefeldt K
• Article: NEW ENGLAND JOURNAL OF MEDICINE. 2017;377(11):1033-1042

  Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke

  Sondergaard L; Kasner SE; Rhodes JF; Andersen G; Iversen HK; Nielsen-Kudsk JE; Settergren M; Sjostrand C; Roine RO; Hildick-Smith D; Spence JD; Thomassen L
• Conference publication: CEPHALALGIA. 2017;37:240-241

  INVOLVEMENT OF THE MIGRAINE SNP rs1835740 IN CLUSTER HEADACHE

  Ran C; Fourier C; Steinberg A; Sjostrand C; Waldenlind E; Belin AC
• Conference publication: CEPHALALGIA. 2017;37:212

  Cluster Headache - Clinical pattern and a new severity scale in a Swedish cohort

  Steinberg A; Fourier C; Ran C; Waldenlind E; Sjostrand C; Belin AC
• Conference publication: CEPHALALGIA. 2017;37:21-22

  The clock gene CRY1 is associated with cluster headache in Sweden

  Fourier C; Ran C; Steinberg A; Sjostrand C; Waldenlind E; Belin AC
• Article: SUPPORTIVE CARE IN CANCER. 2017;25(9):2683-2690

  Voice rehabilitation after laryngeal cancer: Associated effects on psychological well-being

  Bergstrom L; Ward EC; Finizia C
• Article: PLOS ONE. 2017;12(8):e0183571

  Elevated plasma homocysteine upon ischemic stroke is associated with increased long-term mortality in women

  Markaki I; Klironomos S; Kostulas K; Sjostrand C
• Article: JOURNAL OF HEADACHE AND PAIN. 2017;18(1):88

  Screening of genetic variants in ADCYAP1R1, MME and 14q21 in a Swedish cluster headache cohort

  Ran C; Fourier C; Michalska JM; Steinberg A; Sjostrand C; Waldenlind E; Belin AC
• Journal article: EUROPEAN HEART JOURNAL. 2017;38(suppl_1):ehx504.4159

  4159The soluble IL6 receptor as a predictor for early cardiovascular events

  Ziegler L; Gajulapuri A; Frumento P; Wallen H; De Faire U; Gigante B
• Conference publication: EUROPEAN HEART JOURNAL. 2017;38:857

  The soluble IL6 receptor as a predictor for early cardiovascular events

  Ziegler L; Gajulapuri A; Frumento P; Wallen H; De Faire U; Gigante B
• Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(9):1249-1257

  Improved treatment satisfaction after switching therapy to rituximab in relapsing-remitting MS

  de Flon P; Laurell K; Soderstrom L; Gunnarsson M; Svenningsson A
• Article: PLOS ONE. 2017;12(7):e0177477

  A comparative study of patients' activities and interactions in a stroke unit before and after reconstruction-The significance of the built environment

  Anaker A; von Koch L; Sjostrand C; Bernhardt J; Elf M
• Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2017;24:577

  Neurofilament light in serum for monitoring multiple sclerosis: A new quantitative tool for measuring disease activity and therapeutic response

  Novakova L; Zetterberg H; Axelsson M; Sundstrom P; Khademi M; Gunnarsson M; Malmestrom C; Svenningsson A; Olsson T; Piehl F; Blennow K; Lycke J
• Other: LAKARTIDNINGEN. 2017;114:ELAI

  [Rapid improvement of tick-borne encephalitis after treatment with corticosteroids].

  Wengse C; Ericsson J; Hallberg S; Ursing J
• Article: IMMUNOLOGIC RESEARCH. 2017;65(3):706-712

  Validation of an enzyme-linked immunosorbent assay for the quantification of citrullinated histone H3 as a marker for neutrophil extracellular traps in human plasma

  Thalin C; Daleskog M; Goransson SP; Schatzberg D; Lasselin J; Laska A-C; Kallner A; Helleday T; Wallen H; Demers M
• Article: JOURNAL OF INTERVENTIONAL CARDIOLOGY. 2017;30(3):242-248

  Impaired endothelial function in patients with cryptogenic stroke and patent foramen ovale is not affected by closure

  Lantz M; Kostulas K; Settergren M; Sjostrand C
• Review: MATURITAS. 2017;99:47-50

  Sex differences in the presentation of stroke

  Berglund A; Schenck-Gustafsson K; von Euler M
• Conference publication: INTERNATIONAL JOURNAL OF STROKE. 2017;15(1_SUPPL):3-4

  EFFICACY OF FLUOXETINE - A RANDOMIZED CONTROLLED TRIAL IN STROKE (EFFECTS)

  Lundstrom E; Isaksson E; Nasman P; Wester P; Martensson B; Norrving B; Wallen H; Borg J; Dennis M; Mead G; Hankey G; Hackett M; Stibrant-Sunnerhagen K
• Doctoral thesis: 2017

  Aspects of migraine and patent foramen ovale in ischemic stroke

  Lantz M
• Other: LAKARTIDNINGEN. 2017;114:ECUU

  [Encefalopathy as a side effect of metronidazole therapy – a case report].

  Karayianni M; von Heijne A; Laska A-C
• Article: JOURNAL OF INTERNAL MEDICINE. 2017;281(3):273-283

  Randomized assessment of imatinib in patients with acute ischaemic stroke treated with intravenous thrombolysis

  Wahlgren N; Thoren M; Hojeberg B; Kall T-B; Laska A-C; Sjostrand C; Hoijer J; Almqvist H; Holmin S; Lilja A; Fredriksson L; Lawrence D; Eriksson U; Ahmed N
• Review: PLOS ONE. 2017;12(1):e0170018

  Brain Parenchymal Fraction in Healthy Adults-A Systematic Review of the Literature

  Vagberg M; Granasen G; Svenningsson A
• Review: APHASIOLOGY. 2017;31(1):122-128

  Patients with aphasia and an infarct in Wernicke's area benefit from early intensive speech and language therapy

  Dembrower KEH; von Heijne A; Laska AC; Laurencikas E
• Review: ACTA NEUROLOGICA SCANDINAVICA. 2017;135(1):17-24

  Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society

  Vagberg M; Axelsson M; Birgander R; Burman J; Cananau C; Forslin Y; Granberg T; Gunnarsson M; von Heijne A; Jonsson L; Karrenbauer VD; Larsson E-M; Lindqvist T; Lycke J; Lonn L; Mentesidou E; Muller S; Nilsson P; Piehl F; Svenningsson A; Vrethem M; Wikstrom J
• Article: JOURNAL OF NEURORADIOLOGY. 2016;43(6):384-391

  Brain parenchymal fraction in an age-stratified healthy population - determined by MRI using manual segmentation and three automated segmentation methods

  Vagberg M; Ambarki K; Lindqvist T; Birgander R; Svenningsson A
• Article: IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE. 2016;69(11-12):397-402

  HOW TO MINIMIZE THE RISK FOR HEADACHE? A LUMBAR PUNCTURE PRACTICE QUESTIONNAIRE STUDY

  Salzer J; Rajda C; Sundstrom P; Vagberg M; Vecsei L; Svenningsson A
• Article: NEUROLOGY. 2016;87(20):2074-2081

  Rituximab in multiple sclerosis A retrospective observational study on safety and efficacy

  Salzer J; Svenningsson R; Alping P; Novakova L; Bjorck A; Fink K; Islam-Jakobsson P; Malmestrm C; Axelsson M; Vagberg M; Sundstrom P; Lycke J; Piehl F; Svenningsson A
• Letter: ANNALS OF NEUROLOGY. 2016;80(5):791-792

  Rituximab versus fingolimod after natalizumab in multiple sclerosis: Also consider progressive multifocal leukoencephalopathy risk Reply

  Alping P; Frisell T; Svenningsson A; Piehl F
• Article: NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2016;3(5):e271

  Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS

  Bergman J; Dring A; Zetterberg H; Blennow K; Norgren N; Gilthorpe J; Bergenheim T; Svenningsson A
• Conference publication: INTERNATIONAL JOURNAL OF STROKE. 2016;11(SUPP 3):122

  EFFECTS OF ALTEPLASE WITHIN 6 HOURS OF ISCHAEMIC STROKE ON SURVIVAL UP TO 3 YEARS: RESULTS FROM THE THIRD INTERNATIONAL STROKE TRIAL (IST-3)

  Berge E; Cohen G; Roaldsen MB; Lundstrom E; Isaksson E; Rudberg AS; Slot KB; Forbes J; Smith J; Drever J; Wardlaw JM; Lindley RI; Sandercock PAG; Whiteley WN
• Conference publication: CEPHALALGIA. 2016;36:79

  GENETIC SCREENING OF CLOCK IN A SWEDISH CLUSTER HEADACHE CASE-CONTROL MATERIAL

  Fourier C; Zinnegger M; Steinberg A; Sjostrand C; Waldenlind E; Ran C; Belin AC
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2016;22:511

  Cytokine levels in interstitial brain fluid in progressive multiple sclerosis measured via intracerebral microdialysis

  Bergman J; Dring A; Wuolikainen A; Gilthorpe J; Bergenheim T; Svenningsson A
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2016;22:336-337

  A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of natalizumab (IMSE 1)

  Johansson S; Forsberg L; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Walentin F; Martin C; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2016;22:49

  Rituximab in multiple sclerosis; data from the swedish MS registry.

  Alping P; Svenningsson A; Salzer J; Burman J; Dahle C; Fink K; Hillert J; Lycke J; Landtblom A-M; Martin C; Nilsson P; Walentin F; Olsson T; Frisell T; Piehl F
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2016;22:622

  Changes of cerebrospinal fluid cytokine profile as a result of switching from first line MS-therapies to rituximab

  de Flon P; Soderstrom L; Laurell K; Gunnarsson M; Svenningsson A
• Article: LARYNGOSCOPE. 2016;126(9):2029-2035

  Voice rehabilitation for laryngeal cancer patients: Functional outcomes and patient perceptions

  Bergstrom L; Ward EC; Finizia C
• Article: LANCET NEUROLOGY. 2016;15(10):1028-1034

  Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial

  Berge E; Cohen G; Roaldsen MB; Lundstrom E; Isaksson E; Rudberg A-S; Slot KB; Forbes J; Smith J; Drever J; Wardlaw JM; Lindley RI; Sandercock PAG; Whiteley WN
• Article: INTERNATIONAL JOURNAL OF STROKE. 2016;11(6):683-694

  Intravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: Protocol for a randomized, placebo-controlled trial.

  Sprigg N; Robson K; Bath P; Dineen R; Roberts I; Robinson T; Roffe C; Werring D; Al-Shahi Salman R; Pocock S; Duley L; England T; Whynes D; Ciccone A; Laska AC; Christensen H; Ozturk S; Collins R; Bereczki D; Egea-Guerrero JJ; Law ZK; Czlonkowska A; Seiffge D; Beredzie M; TICH-2 Investigators
• Article: NEUROLOGY. 2016;87(2):141-147

  Reduced inflammation in relapsing-remitting multiple sclerosis after therapy switch to rituximab

  de Flon P; Gunnarsson M; Laurell K; Soderstrom L; Birgander R; Lindqvist T; Krauss W; Dring A; Bergman J; Sundstrom P; Svenningsson A
• Article: NEW ENGLAND JOURNAL OF MEDICINE. 2016;375(1):35-43

  Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack.

  Johnston SC; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Jonasson J; Minematsu K; Molina CA; Wang Y; Wong KSL; SOCRATES Steering Committee and Investigators
• Article: MULTIPLE SCLEROSIS JOURNAL. 2016;22(8):1027-1031

  Vitamin D and axonal injury in multiple sclerosis

  Sandberg L; Bistrom M; Salzer J; Vagberg M; Svenningsson A; Sundstrom P
• Article: ACTA ONCOLOGICA. 2016;55(6):693-699

  A prospective longitudinal study of voice characteristics and health-related quality of life outcomes following laryngeal cancer treatment with radiotherapy

  Karlsson T; Bergstrom L; Ward E; Finizia C
• Article: ANNALS OF NEUROLOGY. 2016;79(6):950-958

  Rituximab versus Fingolimod after Natalizumab in Multiple Sclerosis Patients

  Alping P; Frisell T; Novakova L; Islam-Jakobsson P; Salzer J; Bjorck A; Axelsson M; Malmestrom C; Fink K; Lycke J; Svenningsson A; Piehl F
• Article: HEADACHE. 2016;56(5):835-840

  Screening of Two ADH4 Variations in a Swedish Cluster Headache Case-Control Material

  Fourier C; Ran C; Steinberg A; Sjostrand C; Waldenlind E; Belin AC
• Article: EUROPEAN HEART JOURNAL. 2016;37(14):1145-1153

  XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation.

  Camm AJ; Amarenco P; Haas S; Hess S; Kirchhof P; Kuhls S; van Eickels M; Turpie AGG; XANTUS Investigators
• Article: JOURNAL OF NEUROIMMUNOLOGY. 2016;292:40-44

  Cerebrospinal fluid concentration of Galectin-9 is increased in secondary progressive multiple sclerosis

  Burman J; Svenningsson A
• Article: THROMBOSIS RESEARCH. 2016;139:56-64

  NETosis promotes cancer-associated arterial microthrombosis presenting as ischemic stroke with troponin elevation

  Thalin C; Demers M; Blomgren B; Wong SL; von Arbin M; von Heijne A; Laska AC; Wallen H; Wagner DD; Aspberg S
• Review: CLINICAL RADIOLOGY. 2016;71(3):293-303

  Intracranial vessel wall MRI

  Bhogal P; Navaei E; Makalanda HLD; Brouwer PA; Sjostrand C; Mandell DM; Lilja A
• Article: NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2016;3(1):e191

  Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination

  Al Nimer F; Elliott C; Bergman J; Khademi M; Dring AM; Aeinehband S; Bergenheim T; Christensen JR; Sellebjerg F; Svenningsson A; Linington C; Olsson T; Piehl F
• Article: JOURNAL OF NEUROLOGY. 2016;263(2):322-326

  Rituximab in paediatric onset multiple sclerosis: a case series

  Salzer J; Lycke J; Wickstrom R; Naver H; Piehl F; Svenningsson A
• Journal article: OTORHINOLARYNGOLOGY-HEAD AND NECK SURGERY. 2016;1(2):33-37

  The impact of laryngeal biopsy on voice outcomes: a pilot study

  Bergström L; Ward EC; Finizia C
• Article: ACTA NEUROLOGICA SCANDINAVICA. 2015;132(6):389-394

  Increasing prevalence of multiple sclerosis in Vasterbotten County of Sweden

  Svenningsson A; Salzer J; Vagberg M; Sundstrom P; Svenningsson A
• Article: JOURNAL OF ADVANCED NURSING. 2015;71(11):2609-2621

  Factors facilitating or hampering nurses identification of stroke in emergency calls

  Berglund A; Heikkila K; Bohm K; Schenck-Gustafsson K; von Euler M
• Review: JOURNAL OF STROKE & CEREBROVASCULAR DISEASES. 2015;24(10):2390-2396

  Elevated Troponin Levels in Acute Stroke Patients Predict Long-term Mortality

  Thalin C; Rudberg A-S; Johansson F; Jonsson F; Laska AC; Nygren AT; von Arbin M; Wallen H; Aspberg S
• Article: JOURNAL OF STROKE & CEREBROVASCULAR DISEASES. 2015;24(10):2348-2357

  Clopidogrel Resistance after Minor Ischemic Stroke or Transient Ischemic Attack is Associated with Radiological Cerebral Small-Vessel Disease

  Lundstrom A; Wallen H; von Arbin M; Jorneskog G; Gigante B; Dembrower KH; Laurencikas E; Laska AC
• Article: INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY. 2015;17(5):470-480

  Motor functions and adaptive behaviour in children with childhood apraxia of speech

  Tukel S; Bjorelius H; Henningsson G; McAllister A; Eliasson AC
• Article: MULTIPLE SCLEROSIS JOURNAL - EXPERIMENTAL, TRANSLATIONAL AND CLINICAL. 2015;1:2055217315608203

  Improved working ability in a contemporary MS population compared with a historic non-treated MS population in the same geographic area of Sweden.

  Wickström A; Sundström P; Wickström L; Dahle C; Vrethem M; Svenningsson A
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2015;21:574

  Rituximab in multiple sclerosis, a long term safety and efficacy study

  Islam-Jakobsson P; Alping P; Salzer J; Bjorck A; Fink K; Frisell T; Piehl F; Svenningsson A
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2015;21:555

  Superior efficacy and tolerability of rituximab as compared to fingolimod for MS patients switching from natalizumab due to positive JC virus serology

  Alping P; Islam-Jakobsson P; Novakova L; Salzer J; Bjorck A; Axelsson M; Malmestrom C; Fink K; Frisell T; Lycke J; Svenningsson A; Piehl F
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2015;21:380

  Rituximab in paediatric MS

  Salzer J; Wickstrom R; Piehl F; Lycke J; Svenningsson A
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2015;21:285-286

  A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and efficacy of natalizumab

  Johansson S; Forsberg L; Hillert J; Nilsson P; Dahle C; Svenningsson A; Lycke J; Landtblom A-M; Burman J; Walentin F; Martin C; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2015;21:286-287

  A Swedish nationwide pharmaco-epidemiological and genetic study (IMSE) of the long-term safety and efficacy of dimethyl fumarate

  Forsberg L; Johansson S; Nordin N; Hillert J; Svenningsson A; Lycke J; Burman J; Landtblom A-M; Walentin F; Martin C; Nilsson P; Dahle C; Piehl F; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2015;21:284-285

  The IMSE 2 study: a Swedish nationwide pharmaco-epidemiological and genetic study focused on long-term safety and efficacy of fingolimod

  Johansson S; Forsberg L; Nordin N; Hillert J; Svenningsson A; Lycke J; Burman J; Landtblom A-M; Walentin F; Martin C; Nilsson P; Dahle C; Piehl F; Olsson T
• Article: PLOS ONE. 2015;10(8):e0135886

  Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction

  Vagberg M; Norgren N; Dring A; Lindqvist T; Birgander R; Zetterberg H; Svenningsson A
• Article: PLOS ONE. 2015;10(7):e0132177

  Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament Light

  Al Nimer F; Thelin E; Nystrom H; Dring AM; Svenningsson A; Piehl F; Nelson DW; Bellander B-M
• Article: MULTIPLE SCLEROSIS JOURNAL. 2015;21(8):1036-1044

  Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF

  Warnke C; Stettner M; Lehmensiek V; Dehmel T; Mausberg AK; von Geldern G; Gold R; Kuempfel T; Hohlfeld R; Maeurer M; Stangel M; Straeten V; Limmroth V; Weber T; Kleinschnitz C; Wattjes MP; Svenningsson A; Olsson T; Hartung H-P; Hermsen D; Tumani H; Adams O; Kieseier BC
• Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2015;13:699

  Clopidogrel resistance after minor ischemic stroke or TIA is associated to pre-diabetes, hypertension and cerebral microangiopathy

  Lundstrom A; Laska AC; Gigante B; von Arbin M; Jorneskog G; Laurencikas E; Dembrower KH; Wallen H
• Doctoral thesis: 2015

  Prehospital identification and priority of acute stroke

  Berglund A
• Conference publication: CEPHALALGIA. 2015;35:262

  Genetic screening and characterization of hyporcretin receptor 2 in cluster headache in Sweden

  Ran C; Xiang F; Mattsson A; Sjostrand C; Steinberg A; Waldenlind E; Belin AC
• Article: ACTA NEUROLOGICA SCANDINAVICA. 2015;131(5):290-297

  Prevalence of migraine headache in an in-patient stroke population

  Lantz M; Kostulas K; Waldenlind E; Sjostrand C
• Article: BMJ OPEN. 2015;5(4):e007661

  Identification of stroke during the emergency call: a descriptive study of callers' presentation of stroke

  Berglund A; von Euler M; Schenck-Gustafsson K; Castren M; Bohm K
• Article: NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2015;2(2):e79

  Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally

  Svenningsson A; Bergman J; Dring A; Vagberg M; Birgander R; Lindqvist T; Gilthorpe J; Bergenheim T
• Conference publication: INTERNATIONAL JOURNAL OF STROKE. 2015;10:113

  Obstacles and facilitators in emergency calls about stroke: Nurses' skills enable identification of stroke

  Berglund A; Heikkila K; Bohm K; Schenck-Gustafsson K; von Euler M
• Article: BRAIN. 2015;138(Pt 4):963-973

  Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study

  Svenningsson P; Rosenblad C; Arvidsson KAE; Wictorin K; Keywood C; Shankar B; Lowe DA; Bjorklund A; Widner H
• Article: FRONTIERS IN NEUROLOGY. 2015;6:18

  Improvement in fatigue during natalizumab treatment is linked to improvement in depression and day-time sleepiness

  Penner I-K; Sivertsdotter EC; Celius EG; Fuchs S; Schreiber K; Berko S; Svenningsson A
• Article: LANCET. 2015;385(9968):617-628

  Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial.

  ENOS Trial Investigators
• Article: NEUROLOGICAL RESEARCH. 2015;37(1):92-94

  Lumbar puncture preferences among Swedish neurologists

  Salzer J; Sundstroem P; Vagberg M; Svenningsson A
• Article: MULTIPLE SCLEROSIS JOURNAL. 2015;21(1):48-56

  Age-dependent effects on the treatment response of natalizumab in MS patients

  Matell H; Lycke J; Svenningsson A; Holmen C; Khademi M; Hillert J; Olsson T; Piehl F
• Article: JOURNAL OF NEUROIMMUNOLOGY. 2014;277(1-2):153-159

  The cerebrospinal fluid cytokine signature of multiple sclerosis: A homogenous response that does not conform to the Th1/Th2/Th17 convention

  Burman J; Svensson E; Fransson M; Loskog ASI; Zetterberg H; Raininko R; Svenningsson A; Fagius J; Mangsbo SM
• Article: ANNALS OF NEUROLOGY. 2014;76(6):792-801

  Cerebrospinal Fluid JC Virus Antibody Index for Diagnosis of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

  Warnke C; von Geldern G; Markwerth P; Dehmel T; Hoepner R; Gold R; Pawlita M; Kuempfel T; Maeurer M; Stangel M; Wegner F; Hohlfeld R; Straeten V; Limmroth V; Weber T; Hermsen D; Kleinschnitz C; Hartung H-P; Wattjes MP; Svenningson A; Major E; Olsson T; Kieseier BC; Adams O
• Letter: NEUROLOGY. 2014;82(22):2017-2025

  Initial cognitive decline is associated with cortical thinning in early Parkinson disease

  Pereira JB; Svenningsson P; Weintraub D; Bronnick K; Lebedev A; Westman E; Aarsland D
• Editorial: APHASIOLOGY. 2014;28(11):1385-1392

  Time for a step change? Improving the efficiency, relevance, reliability, validity and transparency of aphasia rehabilitation research through core outcome measures, a common data set and improved reporting criteria.

  Brady MC; Ali M; Fyndanis C; Kambanaros M; Grohmann KK; Laska A-C; Hernández-Sacristán C; Varlokosta S
• Letter: LAKARTIDNINGEN. 2014;111(40):1725

  [Swedish neurologists--unusually disobedient when it comes to lumbar punctures].

  Salzer J; Vågber M; Svenningsson A; Sunddström P
• Article: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2014;85(10):1116-1121

  Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience

  Burman J; Iacobaeus E; Svenningsson A; Lycke J; Gunnarsson M; Nilsson P; Vrethem M; Fredrikson S; Martin C; Sandstedt A; Uggla B; Lenhoff S; Johansson J-E; Isaksson C; Hagglund H; Carlson K; Fagius J
• Article: INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY. 2014;16(5):517-528

  Cervical auscultation as an adjunct to the clinical swallow examination: A comparison with fibre-optic endoscopic evaluation of swallowing

  Bergstrom L; Svensson P; Hartelius L
• Conference publication: EUROPEAN HEART JOURNAL. 2014;35:992

  Cancer associated microthrombosis; a contributing factor to troponin elevation in acute ischemic stroke

  Thalin C; Blomgren B; Lundstrom A; Mobarrez F; Laska AC; Von Arbin M; Wallen H; Aspberg S
• Article: INTERNATIONAL JOURNAL OF STROKE. 2014;9(6):711-720

  Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial

  Bath PMW; Adami A; Bereczki D; Berge E; Beridze M; Cala L; Casado A; Caso V; Chang HM; Christensen H; Collins R; Czlonkowska A; Dineen RA; El Etribi A; Ghani AR; Gommans J; Koumellis P; Laska AC; Lees KR; Navarro J; Ntaios G; Ozturk S; Phillips S; Pocock S; Prasad K; Scutt P; de Silva HA; Szatmari S; Diez-Tejedor E; Utton S; Wang Y-J; Wardlaw JM; Whynes D; Wong L; Woodhouse L; Sprigg N
• Letter: LANCET. 2014;384(9940):303-304

  International comparisons of acute myocardial infarction

  Ejerhed J; Nordenstedt H; Laska A-C
• Article: MULTIPLE SCLEROSIS JOURNAL. 2014;20(8):1095-1101

  Reduced sick leave in multiple sclerosis after one year of natalizumab treatment. A prospective ad hoc analysis of the TYNERGY trial

  Wickstrom A; Dahle C; Vrethem M; Svenningsson A
• Article: JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS. 2014;2(2):2324709614539283

  Trousseau's Syndrome, a Previously Unrecognized Condition in Acute Ischemic Stroke Associated With Myocardial Injury

  Thalin C; Blomgren B; Mobarrez F; Lundstrom A; Laska AC; von Arbin M; von Heijne A; Rooth E; Wallen H; Aspberg S
• Article: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2014;85(6):618-624

  Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP

  Press R; Askmark H; Svenningsson A; Andersen O; Axelson HW; Stroemberg U; Wahlin A; Isaksson C; Johansson J-EJ; Haegglund H
• Conference publication: BONE MARROW TRANSPLANTATION. 2014;49:S41-S42

  AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR MULTIPLE SCLEROSIS: THE SWEDISH EXPERIENCE

  Hagglund HG; Fagius J; Iacobaeus E; Svenningsson A; Lycke J; Gunnarsson M; Nilsson P; Vrethem M; Fredrikson S; Martin C; Sandstedt A; Uggla B; Lenhoff S; Johansson J-E; Isaksson C; Carlson K; Burman J
• Conference publication: CEREBROVASCULAR DISEASES. 2014;37:230

  Cancer associated generalized thrombosis contributing to elevated levels of plasma troponinin A patients with acute ischemic stroke

  Thalin C; Lundstrom A; Blomgren B; Mobarrez F; Laska AC; von Arbin M; Wallen H; Aspberg S
• Article: MULTIPLE SCLEROSIS JOURNAL. 2014;20(1):43-50

  Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis

  Axelsson M; Malmestrom C; Gunnarsson M; Zetterberg H; Sundstrom P; Lycke J; Svenningsson A
• Article: PLATELETS. 2014;25(2):102-110

  Glucose intolerance and insulin resistance as predictors of low platelet response to clopidogrel in patients with minor ischemic stroke or TIA

  Lundstrom A; Laska A-C; Von Arbin M; Jorneskog G; Wallen H
• Article: JOURNAL OF PALLIATIVE CARE. 2014;30(2):108-115

  Experience of Guilt and Strategies for Coping with Guilt in Patients with Severe COPD: A qualitative interview study

  Strang S; Farrell M; Larsson L-O; Sjostrand C; Gunnarsson A; Ekberg-Jansson A; Strang P
• Article: CEREBROVASCULAR DISEASES. 2014;37(3):212-216

  Face Arm Speech Time Test Use in the Prehospital Setting, Better in the Ambulance than in the Emergency Medical Communication Center

  Berglund A; Svensson L; Wahlgren N; von Euler M
• Article: JOURNAL OF STROKE & CEREBROVASCULAR DISEASES. 2014;23(1):e47-e53

  High Cholesterol Levels Are Associated with Improved Long-term Survival after Acute Ischemic Stroke

  Markaki I; Nilsson U; Kostulas K; Sjostrand C
• Article: STROKE. 2013;44(11):3161-3165

  How well do standard stroke outcome measures reflect quality of life? A retrospective analysis of clinical trial data.

  Ali M; Fulton R; Quinn T; Brady M; VISTA Collaboration
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2013;19(11):445-446

  The immunomodulation and multiple sclerosis epidemiology (IMSE II) study: a Swedish nationwide pharmaco-epidemiological and genetic study focussed on long-term safety and efficacy of fingolimod (Gilenya®)

  Nordin N; Hillert J; Piehl F; Svenningsson A; Lycke J; Fagius J; Walentin F; Martin C; Nilsson P; Feltelius N; Dahle C; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2013;19(11):205

  The immunomodulation and multiple sclerosis epidemiology (IMSE) study; a Swedish nationwide pharmaco-epidemiological and genetic study focussed on long-term safety and efficacy of natalizumab (Tysabri)

  Jonsson L; Piehl F; Hillert J; Nilsson P; Dahle C; Feltelius N; Svenningsson A; Lycke J; Fagius J; Wallentin F; Martin C; Olsson T
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2013;19(11):468-469

  Haematopoietic stem cell transplantation for multiple sclerosis: the Swedish experience

  Burman J; Iacobaeus E; Svenningsson A; Lycke J; Gunnarsson M; Nilsson P; Vrethem M; Fredrikson S; Martin C; Fagius J
• Article: SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION. 2013;73(7):576-584

  Thrombin generation in acute cardioembolic and non-cardioembolic ischemic stroke

  Rooth E; Sobocinski-Doliwa P; Antovic J; Kull VF; Von Arbin M; Rosenqvist M; Wallen H
• Article: HEALTH EXPECTATIONS. 2013;16(3):e24-e35

  What aspects of rehabilitation provision contribute to self-reported met needs for rehabilitation one year after stroke - amount, place, operator or timing?

  Tistad M; von Koch L; Sjostrand C; Tham K; Ytterberg C
• Article: JOURNAL OF STROKE & CEREBROVASCULAR DISEASES. 2013;22(6):841-845

  Ischemic Stroke and Patent Foramen Ovale: Risk Factors and Genetic Profile

  Lantz M; Sjostrand C; Kostulas K
• Article: PLOS ONE. 2013;8(5):e63172

  Intense Inflammation and Nerve Damage in Early Multiple Sclerosis Subsides at Older Age: A Reflection by Cerebrospinal Fluid Biomarkers

  Khademi M; Dring AM; Gilthorpe JD; Wuolikainen A; Al Nimer F; Harris RA; Andersson M; Brundin L; Piehl F; Olsson T; Svenningsson A
• Conference publication: BONE MARROW TRANSPLANTATION. 2013;48:S336

  Autologous haematopoietic stem cell transplantation: a viable treatment option for chronic inflammatory demyelinating polyneuropathy

  Hagglund H; Askmark H; Stromberg U; Axelsson H; Svenningsson A; Isaksson C; Wahlin A; Andersen O; Johansson J; Press R
• Article: ACTA NEUROLOGICA SCANDINAVICA. 2013;127(4):e18-e23

  Migraine-related ischemic stroke?

  Lantz M; Kostulas K; Sjostrand C
• Article: MULTIPLE SCLEROSIS JOURNAL. 2013;19(5):622-630

  Improved ability to work after one year of natalizumab treatment in multiple sclerosis. Analysis of disease-specific and work-related factors that influence the effect of treatment

  Wickstrom A; Nystrom J; Svenningsson A
• Article: PLOS ONE. 2013;8(3):e58643

  Natalizumab Treatment Reduces Fatigue in Multiple Sclerosis. Results from the TYNERGY Trial; A Study in the Real Life Setting

  Svenningsson A; Falk E; Celius EG; Fuchs S; Schreiber K; Berko S; Sun J; Penner I-K
• Editorial: NEUROLOGY. 2013;80(10):965-967

  FATAL NEUROINFLAMMATION IN A CASE OF MULTIPLE SCLEROSIS WITH ANTI-NATALIZUMAB ANTIBODIES

  Svenningsson A; Dring AM; Fogdell-Hahn A; Jones I; Engdahl E; Lundkvist M; Brannstrom T; Gilthorpe JD
• Article: AMERICAN JOURNAL OF NEURORADIOLOGY. 2013;34(3):498-504

  Automated Determination of Brain Parenchymal Fraction in Multiple Sclerosis

  Vagberg M; Lindqvist T; Ambarki K; Warntjes JBM; Sundstrom P; Birgander R; Svenningsson A
• Article: NEW ENGLAND JOURNAL OF MEDICINE. 2013;368(6):513-523

  Rivaroxaban for thromboprophylaxis in acutely ill medical patients.

  Cohen AT; Spiro TE; Büller HR; Haskell L; Hu D; Hull R; Mebazaa A; Merli G; Schellong S; Spyropoulos AC; Tapson V; MAGELLAN Investigators
• Meeting abstract: JOURNAL OF HEADACHE AND PAIN. 2013;14:p34

  Elucidating the molecular genetic basis of cluster headache: delineation of the genetic architecture by exome sequencing

  Southgate L; Scollen S; He W; Moss A; Simpson MA; Zhang B; Xi L; Schlitt T; Weale ME; Hyde CL; Stephens JC; Sjostrand C; Russell MB; Leone M; John SL; Trembath RC
• Conference publication: CEREBROVASCULAR DISEASES. 2013;35:438

  The prevalence of migraine in an in-patient stroke population.

  Lantz M; Kostulas K; Waldenlind E; Sjostrand C
• Conference publication: CEREBROVASCULAR DISEASES. 2013;35:333

  Higher cholesterol levels at admission but also statin treatment are associated with improved survival after ischemic stroke.

  Nilsson U; Markaki I; Kostulas K; Sjostrand C
• Journal article: EUROPEAN NEUROLOGICAL REVIEW. 2013;8((Suppl.1)):10

  Clinical, Biochemical and Imaging Parameters that may be Predictive of High Disease Activity, Rapid Progression or Increased Disability in Multiple Sclerosis

  Svenningsson A; Hendin BA
• Journal article: JOURNAL OF HEADACHE AND PAIN. 2013;1(Suppl 1):p34

  Elucidating the molecular genetic basis of cluster headache: delineation of the genetic architecture by exome sequencing

  Southgate L; Scollen S; He W; Moss A; Simpson M; Zhang B; Xi L; Schlitt T; Weale M; Hyde C; Stephens J; Sjöstrand C; Russell M; Leone M; John S; Trembath R
• Conference publication: JOURNAL OF NEUROIMMUNOLOGY. 2012;253(1-2):100

  Multivariate analysis of inflammatory and neuronal injury markers in cerebrospinal fluid of multiple sclerosis: Higher levels are associated with younger age

  Khademi M; Dring A; Gilthorpe J; Wuolikainen A; Al Nimer F; Harris R; Andersson M; Brundin L; Piehl F; Olsson T; Svenningsson A
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2012;18:433-434

  The "Immunomodulation and Multiple Sclerosis Epidemiology" (IMSE) study; A Swedish nationwide pharmaco-epidemiological and genetic study focused on long-term safety and efficacy of natalizumab (Tysabri)

  Holmen C; Piehl F; Hillert J; Nilsson P; Dahle C; Feltelius N; Svenningsson A; Lycke J; Fagius J; Wallentin F; Martin C; Olsson T
• Article: STROKE. 2012;43(10):2666-2670

  Higher Prehospital Priority Level of Stroke Improves Thrombolysis Frequency and Time to Stroke Unit The Hyper Acute STroke Alarm (HASTA) Study

  Berglund A; Svensson L; Sjostrand C; von Arbin M; von Euler M; Wahlgren N; Engerstrom L; Hojeberg B; Kall T-B; Mjornheim S; Engqvist A
• Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2012;19:751

  The 'Immunomodulation and Multiple Sclerosis Epidemiology' (IMSE) study: a Swedish nationwide pharmaco-epidemiological and genetic study focused on long-term safety and efficacy of natalizumab (Tysabri)

  Holmen C; Piehl F; Hillert J; Nilsson P; Dahle C; Feltelius N; Svenningsson A; Lycke J; Fagius J; Valentin F; Martin C; Olsson T
• Article: NEUROLOGICAL RESEARCH. 2012;34(7):730-733

  Humoral immune response to influenza vaccine in natalizumab-treated MS patients

  Vagberg M; Kumlin U; Svenningsson A
• Article: JOURNAL OF CLINICAL NURSING. 2012;21(15-16):2386-2391

  Gender differences in quality of life after stroke and TIA: a cross-sectional survey of out-patients.

  Franzén-Dahlin Å; Laska AC
• Article: EUROPACE. 2012;14(8):1112-1116

  Improved screening for silent atrial fibrillation after ischaemic stroke

  Sobocinski PD; Rooth EA; Kull VF; von Arbin M; Wallen H; Rosenqvist M
• Book chapter: LAKARTIDNINGEN. 2012;p. 1170-1171

  [Treatment of status epilepticus].

  Salzer J; Svenningsson A
• Journal article: NEUROLOGY. 2012;78(Meeting Abstracts 1):p07.081

  Natalizumab Reduces Fatigue as Measured by the Fatigue Scale for Motor and Cognitive Functions (FSMC) - First Results from the TYNERGY Trial (P07.081)

  Svenningsson A; Celius E; Schreiber K; Fuchs S; Falk E; Berko S; Max Moller C; Penner IK
• Journal article: NEUROLOGY. 2012;78(Meeting Abstracts 1):p03.055

  Automated Determination of Brain Parenchymal Fraction in Multiple Sclerosis (P03.055)

  Vagberg M; Lindqvist T; Warntjes M; Sundstrom P; Birgander R; Svenningsson A
• Article: TOPICS IN STROKE REHABILITATION. 2012;19(2):172-181

  Shorter Length of Stay in the Stroke Unit: Comparison Between the 1990s and 2000s

  Tistad M; Ytterberg C; Sjotrand C; Holmqvist LW; von Koch L
• Article: BIODRUGS. 2011;25(5):299-306

  Effect of Treatment with Natalizumab on Ability to Work in People with Multiple Sclerosis Productivity Gain Based on Direct Measurement of Work Capacity before and after 1 Year of Treatment

  Olofsson S; Wickstrom A; Glenngard AH; Persson U; Svenningsson A
• Article: ACTA NEUROLOGICA SCANDINAVICA. 2011;124(2):130-134

  Interleukin-2 gene expression in different phases of episodic cluster headache - a pilot study

  Steinberg A; Sjostrand C; Sominanda A; Fogdell-Hahn A; Remahl AIMN
• Article: LANCET. 2011;377(9782):2013-2022

  Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.

  Bousser M-G; Amarenco P; Chamorro A; Fisher M; Ford I; Fox KM; Hennerici MG; Mattle HP; Rothwell PM; de Cordoüe A; Fratacci M-D; PERFORM Study Investigators
• Letter: ANNALS OF NEUROLOGY. 2011;69(6):1066-1067

  The Neurofilament Light Chain is Not Stable in Vitro Reply

  Gunnarsson M; Malmestrom C; Rosengren L; Lycke J; Svenningsson A
• Article: MULTIPLE SCLEROSIS JOURNAL. 2011;17(6):708-719

  A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis

  Holmen C; Piehl F; Hillert J; Fogdell-Hahn A; Lundkvist M; Karlberg E; Nilsson P; Dahle C; Feltelius N; Svenningsson A; Lycke J; Olsson T
• Other: BMJ EVIDENCE-BASED MEDICINE. 2011;16(2):60-62

  Migraine with aura--indication of an increased risk of hemorrhagic stroke in women (Women's Health Study) and increased risk of overall death in an Icelandic population (Reykjavik Study).

  Sjöstrand C
• Article: LANCET. 2011;377(9767):741-750

  The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.

  Sandset EC; Bath PMW; Boysen G; Jatuzis D; Kõrv J; Lüders S; Murray GD; Richter PS; Roine RO; Terént A; Thijs V; Berge E; SCAST Study Group
• Article: CEREBROVASCULAR DISEASES EXTRA. 2011;1(1):66-74

  A Randomized Controlled Trial on Very Early Speech and Language Therapy in Acute Stroke Patients with Aphasia

  Laska AC; Kahan T; Hellblom A; Murray V; von Arbin M
• Article: ANNALS OF NEUROLOGY. 2011;69(1):83-89

  Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab

  Gunnarsson M; Malmestrom C; Axelsson M; Sundstrom P; Dahle C; Vrethem M; Olsson T; Piehl F; Norgren N; Rosengren L; Svenningsson A; Lycke J
• Article: THROMBOSIS RESEARCH. 2011;127(1):51-56

  Decreased fibrin network permeability and impaired fibrinolysis in the acute and convalescent phase of ischemic stroke

  Rooth E; Wallen NH; Blomback M; He S
• Article: STROKE. 2010;41(11):2552-2558

  Discarding Heparins as Treatment for Progressive Stroke in Sweden 2001 to 2008

  Eriksson M; Stecksen A; Glader E-L; Norrving B; Appelros P; Asberg KH; Stegmayr B; Terent A; Asplund K
• Review: SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE. 2010;18:48

  Early identification and delay to treatment in myocardial infarction and stroke: differences and similarities.

  Herlitz J; Wireklintsundström B; Bång A; Berglund A; Svensson L; Blomstrand C
• Article: CLINICAL NEUROPHARMACOLOGY. 2010;33(5):260-264

  Efficacy and Safety of the Dopaminergic Stabilizer Pridopidine (ACR16) in Patients With Huntington's Disease

  Lundin A; Dietrichs E; Haghighi S; Goller M-L; Heiberg A; Loutfi G; Widner H; Wiktorin K; Wiklund L; Svenningsson A; Sonesson C; Waters N; Waters S; Tedroff J
• Corrigendum: ACTA NEUROLOGICA SCANDINAVICA. 2010;122(1):70-73

  Season of birth and multiple sclerosis in Sweden (vol 121, pg 20, 2010)

  Salzer J; Svenningsson A; Sundstrom P
• Article: JOURNAL OF CLINICAL NURSING. 2010;19(13-14):1855-1860

  Quality of life in chronic disease: a comparison between patients with heart failure and patients with aphasia after stroke

  Franzen-Dahlin A; Karlsson MR; Mejhert M; Laska A-C
• Meeting abstract: JOURNAL OF HYPERTENSION. 2010;28:E88

  ENDOGENOUS THROMBIN POTENTIAL IN PATIENTS WITH ACUTE ISCHEMIC STROKE OR TRANSIENT ISCHEMIC ATTACK

  Rooth E; Sobocinski-Doliwa P; Frykman V; Von Arbin M; Rosenqvist M; Wallen NH
• Review: CURRENT PAIN AND HEADACHE REPORTS. 2010;14(3):244-251

  Migraine and Olfactory Stimuli

  Sjostrand C; Savic I; Laudon-Meyer E; Hillert L; Lodin K; Waldenlind E
• Article: HEADACHE. 2010;50(3):374-382

  Familial Cluster Headache: Demographic Patterns in Affected and Nonaffected

  Sjostrand C; Russell MB; Ekbom K; Waldenlind E
• Article: MULTIPLE SCLEROSIS JOURNAL. 2010;16(3):287-292

  Neurofilament light as a prognostic marker in multiple sclerosis

  Salzer J; Svenningsson A; Sundstrom P
• Article: ACTA NEUROLOGICA SCANDINAVICA. 2010;121(1):20-23

  Season of birth and multiple sclerosis in Sweden

  Salzer J; Svenningsson A; Sundstrom P
• Article: HANDBOOK OF CLINICAL NEUROLOGY. 2010;97:389-411

  Pathophysiology of cluster headache and other trigeminal autonomic cephalalgias.

  Waldenlind E; Sjöstrand C
• Article: STROKE. 2009;40(12):3851-3856

  Patient Dissatisfaction With Acute Stroke Care

  Asplund K; Jonsson F; Eriksson M; Stegmayr B; Appelros P; Norrving B; Terent A; Asberg KH
• Article: LANCET NEUROLOGY. 2009;8(6):519-529

  NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial

  Sorensen PS; Mellgren SI; Svenningsson A; Elovaara I; Frederiksen JL; Beiske AG; Myhr K-M; Sogaard LV; Olsen IC; Wollheim MS
• Review: EXPERT REVIEW OF NEUROTHERAPEUTICS. 2009;9(3):359-368

  Genetic aspects of cluster headache

  Sjostrand C
• Article: NEUROLOGY. 2009;72(8):688-694

  Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack.

  Chaturvedi S; Zivin J; Breazna A; Amarenco P; Callahan A; Goldstein LB; Hennerici M; Sillesen H; Rudolph A; Welch MA; SPARCL Investigators
• Article: CEREBROVASCULAR DISEASES. 2009;27(5):509-518

  Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.

  Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici MG; Mattle HP; Rothwell PM; PERFORM Study Investigators
• Article: STROKE. 2008;39(9):2444-2448

  Relative effects of statin therapy on stroke and cardiovascular events in men and women: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study.

  Goldstein LB; Amarenco P; Lamonte M; Gilbert S; Messig M; Callahan A; Hennerici M; Sillesen H; Welch KMA; SPARCL Investigators
• Article: JOURNAL OF CLINICAL NURSING. 2008;17(12):1574-1580

  Predictors of life situation among significant others of depressed or aphasic stroke patients

  Franzen-Dahlin A; Laska A-C; Larson J; Wredling R; Billing E; Murray V
• Article: TOPICS IN STROKE REHABILITATION. 2008;15(3):256-261

  Design and methods of a randomized controlled trial on early speech and language therapy in patients with acute stroke and aphasia

  Laska AC; Kahan T; Hellblom A; Murray V; von Arbin M
• Review: LAKARTIDNINGEN. 2007;104(23):1816-1819

  [Horton's headache--clinical findings, mechanisms and therapy].

  Meyer EL; Sjöstrand C; Remahl IN; Waldenlind E
• Review: LAKARTIDNINGEN. 2007;104(23):1796-1800

  [Common or dangerous headache?--a clinical challenge].

  Remahl IN; Waldenlind E; Sjöstrand C; Meyer EL
• Article: BLOOD COAGULATION & FIBRINOLYSIS. 2007;18(4):365-370

  Thrombin activatable fibrinolysis inhibitor and its relationship to fibrinolysis and inflammation during the acute and convalescent phase of ischemic stroke

  Rooth E; Wallen H; Antovic A; von Arbin M; Kaponides G; Wahlgren N; Blomback M; Antovic J
• Article: JOURNAL OF REHABILITATION MEDICINE. 2007;39(5):387-392

  Clinical and prognostic properties of standardized and functional aphasia assessments

  Laska AC; Bartfai A; Hellblom A; Murray V; Kahan T
• Doctoral thesis: 2007

  Aphasia in acute stroke

  Laska AC
• Article: CEREBROVASCULAR DISEASES. 2007;24(1):74-79

  Recognition of depression in aphasic stroke patients

  Laska AC; Martensson B; Kahan T; von Arbin M; Murray V
• Conference publication: CEPHALALGIA. 2006;26(11):1363-1364

  A genome-wide scan and HCRTR2 candidate gene analysis in a European cluster headache cohort

  Baumber L; Sjostrand C; Leone M; Harty H; Bussone G; Hillert J; Trembath RC; Russell MB
• Article: HEADACHE. 2006;46(10):1518-1534

  Gene expression profiling in cluster headache:: A pilot microarray study

  Sjostrand C; Duvefelt K; Steinberg A; Remahl IN; Waldenlind E; Hillert J
• Article: NEUROLOGY. 2006;66(12):1888-1893

  A genome-wide scan and HCRTR2 candidate gene analysis in a European cluster headache cohort

  Baumber L; Sjostrand C; Leone M; Harty H; Bussone G; Hillert J; Trembath RC; Russell MB
• Article: CEPHALALGIA. 2005;25(11):1068-1077

  Familial cluster headache. Is atypical cluster headache in family members part of the clinical spectrum?

  Sjöstrand C; Russell MB; Ekbom K; Hillert J; Waldenlind E
• Conference publication: CEPHALALGIA. 2005;25(10):878

  Cytokine expression in different phases of cluster headache

  Steinberg A; Sjöstrand C; Sominanda A; Fogdell-Hahn A; Remahl IN
• Doctoral thesis: 2005

  Clinical and genetic aspects on cluster headache

  Sjöstrand C
• Article: CEREBROVASCULAR DISEASES. 2005;19(2):125-132

  Long-term antidepressant treatment with moclobemide for aphasia in acute stroke patients: A randomised, double-blind, placebo-controlled study

  Laska AC; von Arbin M; Kahan T; Hellblom A; Murray V
• Article: NEUROLOGY. 2004;63(9):1586-1590

  Neurofilament and glial fibrillary acidic protein in multiple sclerosis

  Norgren N; Sundström P; Svenningsson A; Rosengren L; Stigbrand T; Gunnarsson M
• Article: NEUROLOGY. 2004;62(12):2277-2282

  An altered immune response to Epstein-Barr virus in multiple sclerosis -: A prospective study

  Sundström P; Juto P; Wadell G; Hallmans G; Svenningsson A; Nyström L; Dillner J; Forsgren L
• Article: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2004;75(5):711-716

  Clinical characteristics of multiple sclerosis in Vasterbotten County in northern Sweden

  Sundström P; Svenningsson A; Nyström L; Forsgren L
• Article: CEPHALALGIA. 2004;24(2):92-98

  Periods of cluster headache induced by nitrate therapy and spontaneous remission of angina pectoris during active clusters

  Ekbom K; Sjöstrand C; Svensson DA; Waldenlind E
• Corrigendum: CEREBROVASCULAR DISEASES. 2004;17(1):91-92

  Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study (vol 16, pg 389, 2003)

  Clark WM; Dávalos A; Goldstein LB; Kaste M; Leiter L; Zivin J; Sillesen H; Crimmins D; Davis S; Dimmitt S; Donnan G; Frayne J; Freilich D; Gillies D; Mikocki J; Schmidauer C; Schmidt R; De Bleecker J; Deceuninck F; Tack P; Thijs V; Robberecht W; Fernandes JG; Beaudry M; Cote R; Hoyte K; Lebrun LH; Sahlas DJ; Norris J; Selchen D; Shuaib A; Simard D; Spence D; Teal P; Winger M; Matamala G; Jaramillo A; Cifkova R; Kalita Z; Rektor I; Rosolova H; Stipal R; Vaclavik D; Boysen G; Iversen H; Anderson AR; Sillesen H; Hillbom M; Kaste M; Numminen H; Pilke A; Salmivaara A; Pammo O; Sivenius J; Amarenco P; Boulliat J; de Broucker T; Chollet F; Mahagne MH; Milandre L; Moulin T; Roullet E; Bogdahn U; Busse O; Diener HC; Haberl R; Hamann G; Harms L; Hendrich A; Kroczek G; Hennerici M; Knecht S; Henningsen H; Lichy C; Grau A; Sander D; Schneider D; Berrouschot J; Karageorgiou C; Kazis A; Mylonas I; Stathis P; Vogiatzoglou D; Bornstein N; Honigman S; Gross B; Lampl Y; Streifler J; Capurso A; Comi G; Canal N; Frattola L; Gandolfo C; Poloni M; Mamoli A; Senin U; Guerra RR; de Keyser JHA; Boon AM; Haas JA; Kamphuis DJ; De Kort PLM; Koudstaal PJ; Anderson NE; Scott R; Singh GPJ; Czlonkowska A; Drozdowski W; Gralewski Z; Kozubski W; Kuczynska-Zardzewialy A; Podemski R; Stelmasiak Z; Szczudlik A; Correia C; Cunha L; Ferro J; Lietava J; Raslova K; Carr J; Gardiner J; Kruger AJ; Chamorro A; Dávalos A; Egido J; Fernandez O; Marcos JRG; Matias-Guiu J; Jiménez D; Lago A; Martinez CJ; Mostacero E; Rubio F; Sabin JA; Tejedor ED; Torres MG; Trejo J; Vivancos J; Leijd B; Laska AC; Leoo T; Strand T; Terent A; Wägner A; Wallén T; Baumgartner R; Bogousslavsky J; Hungerbühler H; Lyrer P; Mattle H; Bath P; Ekpo EB; Freeman A; Lees KR; Shetty HGM; MacLeod MJ; Dijkhuizen R; MacWalter RS; Sharma AK; Albers G; Altafullah I; Benavente O; Book D; Broderick J; Calder C; Callahan AS; Carlini W; Chaturvedi S; Chippendale T; Clark W; Coull B; Davis P; Devlin T; Dick AR; Dooneief G; Duff RS; Estronza N; Lloyd KA; Forteza A; Frankel MR; Jacobson T; Frey JL; Friday G; Goldstein J; Graham G; Hammer M; Goldstein S; Gebel J; Harper W; Hariharan S; Sen S; Harris J; Hendin B; Hess DC; Hinton R; Hollander J; Hughes RL; Kasner S; Kent TA; Kim L; Kirshner H; LaMonte M; Ledbetter LY; Levin K; Libman R; Matlock J; McDowell P; McGee FE; Meyer B; Jackson C; Minagar A; Pajeau A; Munschauer FE; Munson R; Nash M; Nassief A; Hsu C; Orr SC; Tulyapronchote R; Gomez C; Ratinov G; Salanga V; Dandapani BK; Silliman S; Singer R; Smith D; Sullivan H; Thaler D; Tietjen G; Tuchman M; Uskavitch D; Vicari R; Weinstein R; Wilterdink J; Zweifler R; Verro P; Rymer M; de Bastos M
• Article: MULTIPLE SCLEROSIS JOURNAL. 2003;9(5):515-520

  Sick leave and professional assistance for multiple sclerosis individuals in Vasterbotten County, northern Sweden

  Sundström P; Nyström L; Svenningsson A; Forsgren L
• Conference publication: CEPHALALGIA. 2003;23(7):580

  Periods of cluster headache induced by nitrate therapy and spontaneous remission of angina pectoris during active clusters

  Ekbom K; Sjöstrand C; Svensson DA; Waldenlind E
• Article: CEPHALALGIA. 2002;22(9):758-764

  Analysis of nitric oxide synthase genes in cluster headache

  Sjöstrand C; Modin H; Masterman T; Ekbom K; Waidenlind E; Hillert J
• Article: ANNALS OF NEUROLOGY. 2002;51(4):467-474

  Antibody-mediated suppression of Vβ5.2/5.3⁺ T cells in multiple sclerosis:: Results from an MRI-monitored phase II clinical trial

  Killestein J; Olsson T; Wallström E; Svenningsson A; Khademi M; Blumhardt LD; Fagius J; Hillert J; Landtblom AM; Edenius C; Årfors L; Barkhof F; Polman CH
• Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2002;55(3):264-273

  Differential expression of neurotrophic factors and inflammatory cytokines by myelin basic protein-specific and other recruited T cells infiltrating the central nervous system during experimental autoimmune encephalomyelitis

  Muhallab S; Lundberg C; Gielen AW; Lidman O; Svenningsson A; Piehl F; Olsson T
• Article: CEPHALALGIA. 2001;21(10):953-958

  CACNA1A gene polymorphisms in cluster headache

  Sjöstrand C; Giedratis V; Ekborn K; Waldenlind E; Hillert J
• Article: JOURNAL OF INTERNAL MEDICINE. 2001;249(5):413-422

  Aphasia in acute stroke and relation to outcome

  Laska AC; Hellblom A; Murray V; Kahan T; Von Arbin M
• Article: JOURNAL OF NEUROIMMUNOLOGY. 2001;113(2):202-211

  Intra-CNS activation by antigen-specific T lymphocytes in experimental autoimmune encephalomyelitis

  Muhallab S; Lidman O; Weissert R; Olsson T; Svenningsson A
• Article: CEPHALALGIA. 2000;20(7):653-657

  A follow-up study of 60 patients after an assumed first period of cluster headache.

  Sjöstrand C; Waldenlind E; Ekbom K
• Article: JOURNAL OF NEUROSCIENCE. 2000;20(14):5283-5291

  Neuroprotection by encephalomyelitis:: Rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells

  Hammarberg H; Lidman O; Lundberg C; Eltayeb SY; Gielen AW; Muhallab S; Svenningsson A; Lindå H; van der Meide PH; Cullheim S; Olsson T; Piehl F
• Conference publication: FASEB JOURNAL. 2000;14(6):A1120

  Analysis of CNS-infiltrating myelin specific T lymphocytes by flow cytometry

  Muhallab S; Lidman O; Weissert R; Olsson T; Svenningsson A
• Article: NEUROLOGY. 1999;53(8):1880-1882

  Nitric oxide metabolites in CSF of patients with MS are related to clinical disease course

  Svenningsson A; Petersson AS; Andersen O; Hansson GK
• Review: LAKARTIDNINGEN. 1998;95(49):5623-5630

  [Treatment of multiple sclerosis--1. New drugs may be effective but there still are frequent relapses].

  Svenningsson A; Andersson M; Olsson T
• Review: LAKARTIDNINGEN. 1998;95(49):5631-5635

  [Treatment of multiple sclerosis--2. Application of a new immunological basic research is close].

  Svenningsson A; Andersson M; Olsson T
• Article: JOURNAL OF IMMUNOLOGY. 1998;160(2):681-690

  Molecular and genetic requirements for preferential recruitment of TCRBV8S2⁺ T cells in Lewis rat experimental autoimmune encephalomyelitis

  Weissert R; Svenningsson A; Lobell A; de Graaf KL; Andersson R; Olsson T
• Journal article: CYTOMETRY. 1997;29(2):155-164

  Identification and analysis of macrophage‐derived foam cells from human atherosclerotic lesions by using a “mock” FL3 channel in flow cytometry

  Liu‐Wu Y; Svenningsson A; Stemme S; Holm J; Wiklund O
• Article: CYTOMETRY. 1997;29(2):155-164

  Identification and analysis of macrophage-derived foam cells from human atherosclerotic lesions by using a ''mock'' FL3 channel in flow cytometry

  LiuWu Y; Svenningsson A; Stemme S; Holm J; Wiklund O
• Article: JOURNAL OF NEUROIMMUNOLOGY. 1997;75(1-2):59-68

  Increased expression of B7-1 costimulatory molecule on cerebrospinal fluid cells of patients with multiple sclerosis and infectious central nervous system disease

  Svenningsson A; Dotevall L; Stemme S; Andersen O
• Article: NEUROLOGY. 1996;47(4):895-900

  Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosis

  Andersen O; Lycke J; Tollesson PO; Svenningsson A; Runmarker B; Linde AS; Astrom M; Gjorstrup P; Ekholm S
• Article: MULTIPLE SCLEROSIS JOURNAL. 1996;1(6):348

  Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosis.

  Andersen O; Lycke J; Tollesson PO; Svenningsson A; Runmarker B; Linde AS; Aström M; Gjörstrup P; Ekholm S
• Article: JOURNAL OF NEUROIMMUNOLOGY. 1995;63(1):39-46

  Lymphocyte phenotype and subset distribution in normal cerebrospinal fluid

  Svenningsson A; Andersen O; Edsbagge M; Stemme S
• Article: JOURNAL OF LIPID RESEARCH. 1995;36(11):2282-2290

  DIFFERENTIAL REGULATION OF MACROPHAGE SCAVENGER RECEPTOR ISOFORMS - MESSENGER-RNA QUANTIFICATION USING THE POLYMERASE CHAIN-REACTION

  DUFVA M; SVENNINGSSON A; HANSSON GK
• Journal article: JOURNAL OF NEUROIMMUNOLOGY. 1995;56:26

  Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosis

  Andersen O; Lycke J; Tollesson PO; Svenningsson A; Runmarker B; Linde A; Aström M; Gjörstrup P; Ekholm S
• Article: AUTOIMMUNITY. 1995;21(4):231-239

  Reduced frequency of memory CD8(+) T lymphocytes in cerebrospinal fluid and blood of patients with multiple sclerosis

  Svenningsson A; Andersen O; Hansson GK; Stemme S
• Journal article: CNS DRUGS. 1994;2(2):87-95

  CELL-ADHESION MOLECULES IN MULTIPLE-SCLEROSIS - TARGETS FOR FUTURE THERAPEUTIC STRATEGIES

  SVENNINGSSON A; STEMME S
• Journal article: JOURNAL OF NEUROLOGY. 1994;241(4):204-209

  HUMAN SPUMARETROVIRUS ANTIBODY REACTIVITY IN MULTIPLE-SCLEROSIS

  LYCKE J; SVENNERHOLM B; SVENNINGSSON A; MURANYI W; FLUGEL RM; ANDERSEN O
• Journal article: ACTA NEUROLOGICA SCANDINAVICA. 1993;88(3):199-203

  POSSIBLE ASSOCIATION OF HTLV-I INFECTION AND DEMENTIA

  LYCKE J; SVENNERHOLM B; SVENNINGSSON A; HORAL P; NORDQVISTBRANDT E; ANDERSEN O
• Journal article: ANNALS OF NEUROLOGY. 1993;34(2):155-161

  ADHESION MOLECULE EXPRESSION ON CEREBROSPINAL-FLUID T-LYMPHOCYTES - EVIDENCE FOR COMMON RECRUITMENT MECHANISMS IN MULTIPLE-SCLEROSIS, ASEPTIC-MENINGITIS, AND NORMAL CONTROLS

  SVENNINGSSON A; HANSSON GK; ANDERSEN O; ANDERSSON R; PATARROYO M; STEMME S
• Journal article: ANNALS OF NEUROLOGY. 1992;32(5):711-714

  NO EVIDENCE FOR SPUMAVIRUS OR ONCOVIRUS INFECTION IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS

  SVENNINGSSON A; LYCKE J; SVENNERHOLM B; GRONOWITZ S; ANDERSEN O
• Journal article: LAKARTIDNINGEN. 1992;89(43):3590

  [Conventional methods lead to faulty diagnosis of obscure proteinuria].

  Grubb A; Svenningsson A; Westberg G
• Journal article: AIDS. 1992;6(9):915-923

  HIV-1 IN POSTMORTEM BRAIN-TISSUE FROM PATIENTS WITH AIDS - A COMPARISON OF DIFFERENT DETECTION TECHNIQUES

  SHAPSHAK P; YOSHIOKA M; SUN NCJ; NELSON SJ; RHODES RH; SCHILLER P; RESNICK L; SHAH SM; SVENNINGSSON A; IMAGAWA DT
• Journal article: ACTA NEUROPATHOLOGICA. 1992;84(3):297-306

  SIMULTANEOUS DETECTION OF FERRITIN AND HIV-1 IN REACTIVE MICROGLIA

  YOSHIOKA M; SHAPSHAK P; SUN NCJ; NELSON SJ; SVENNINGSSON A; TATE LG; PARDO V; RESNICK L
• Journal article: AIDS. 1991;5(6):769

  HIV-1 INFECTION OF CD4-NEGATIVE CELLS VIA HTLV PSEUDOVIRONS

  RAFFANTI A; SVENNINGSSON A; RESNICK L
• Conference publication: NEUROLOGY. 1991;41(2):197-202

  THE ROLE OF HTLV IN HIV-1 NEUROLOGIC DISEASE

  BERGER JR; RAFFANTI S; SVENNINGSSON A; MCCARTHY M; SNODGRASS S; RESNICK L
• Journal article: JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 1991;4(3):228-237

  HIV-1 PROPAGATES IN HUMAN NEUROBLASTOMA-CELLS

  SHAPSHAK P; SUN NCJ; RESNICK L; THORNTHWAITE JT; SCHILLER P; YOSHIOKA M; SVENNINGSSON A; TOURTELLOTTE WW; IMAGAWA DT
• Journal article: NEUROLOGY. 1991;41(1):85-87

  TROPICAL SPASTIC PARAPARESIS-LIKE ILLNESS OCCURRING IN A PATIENT DUALLY INFECTED WITH HIV-1 AND HTLV-II

  BERGER JR; SVENNINGSSON A; RAFFANTI S; RESNICK L
• Journal article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 1990;264(19):2501

  DETERMINATION OF HIV-1 STATUS OF DISCARDED SHARPS - POLYMERASE CHAIN-REACTION USING MINUTE QUANTITIES OF BLOOD

  RAFFANTI S; SVENNINGSSON A; RESNICK L
• Journal article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 1990;264(19):2501b-2501

  Determination of HIV-1 status of discarded sharps: polymerase chain reaction using minute quantities of blood

  Raffanti S
• Journal article: ACTA NEUROLOGICA SCANDINAVICA. 1990;82(3):161-168

  INCIDENCE OF MS DURING 2 15-YEAR PERIODS IN THE GOTHENBURG REGION OF SWEDEN

  SVENNINGSSON A; RUNMARKER B; LYCKE J; ANDERSEN O
• Journal article: JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 1990;49(3):351

  COMBINED IMMUNOHISTOCHEMISTRY AND INSITU HYBRIDIZATION TO DETECT HIV IN AIDS BRAIN-CELLS

  SHAPSHAK P; YOSHIOKA M; SVENNINGSSON A; RESNICK L; NELSON S; TATE L
• Visa fler

Medarbetare och kontakt

Gruppledare

• 

  Anders Svenningsson

  Professor/Överläkare

  E-postadress anders.svenningsson@ki.se

Alla medarbetare i gruppen

• 

  Annika Berglund

  Anknuten till Forskning

  E-postadress annika.berglund@ki.se
• 

  Liza Bergström

  Adjungerad Adjunkt | Docent

  E-postadress liza.bergstrom@ki.se
• 

  Helena Björelius

  Doktorand

  E-postadress helena.bjorelius@ki.se
• 

  Kimberley Hammar

  Doktorand

  E-postadress kimberley.hammar@ki.se
• 

  Eva Isaksson

  Anknuten till Forskning

  Telefon +46852482621

  E-postadress eva.isaksson@ki.se
• Sara Jadidi

  Doktorand

  E-postadress sara.jadidi@ki.se
• Sandra Kallin

  Doktorand

  E-postadress sandra.kallin@ki.se
• Oskar Koivisto Taxén

  Doktorand

  E-postadress oskar.koivisto.taxen@ki.se
• Lassi Koski

  Doktorand

  E-postadress lassi.koski@ki.se
• Maria Lantz

  Anknuten till Forskning

  E-postadress maria.lantz@ki.se
• 

  Ann Charlotte Laska

  Anknuten till Forskning | Docent

  E-postadress ann.laska@ki.se
• 

  Susanna Hallberg

  Doktorand

  E-postadress susanna.hallberg@ki.se
• 

  Annika Lundström

  Biträdande Lektor

  Telefon +46852482623

  E-postadress annika.lundstrom@ki.se
• 

  Mihae Roland

  Anknuten till Forskning

  E-postadress mihae.roland@ki.se
• Ann-Sofie Rudberg

  Anknuten till Forskning

  E-postadress ann-sofie.rudberg@ki.se
• Fadi Shawket

  Doktorand

  E-postadress fadi.shawket@ki.se
• 

  Christina Sjöstrand

  Adjungerad Lektor | Docent

  E-postadress christina.sjostrand@ki.se
• 

  Anders Svenningsson

  Professor/Överläkare

  E-postadress anders.svenningsson@ki.se
• Jenny Tegnevi

  Doktorand

  E-postadress jenny.tegnevi@ki.se
• Hedwig Widestedt

  Doktorand

  E-postadress hedwig.widestedt@ki.se
• 

  Louise Ziegler

  Anknuten till Forskning

  E-postadress louise.ziegler@ki.se
• 

  Karolina af Edholm

  Doktorand

  E-postadress karolina.af.edholm@ki.se
• 

  Elisabeth Änggård Rooth

  Anknuten till Forskning

  E-postadress elisabeth.anggard.rooth@ki.se

Besöksadress

Danderyd Hospital, Department of Neurology, Entrévägen 2, Danderyd, StockhOLm, 182 88, Sweden

Postadress

Danderyd Hospital, Department of Neurology, Entrévägen 2, Danderyd, Stockholm, 182 88, Sweden

Forskargrupper